Multi-function bi-polar forceps

Information

  • Patent Grant
  • 9492224
  • Patent Number
    9,492,224
  • Date Filed
    Friday, September 20, 2013
    10 years ago
  • Date Issued
    Tuesday, November 15, 2016
    7 years ago
Abstract
An end effector is disclosed. The end effector includes a first jaw member. The first jaw member comprises a first electrode. The first jaw member defines a first aperture at a distal end. The end effector includes a second jaw member. The second jaw member comprises a second electrode. The second jaw member defines a second aperture at a distal end. The second jaw member is operatively coupled to the first jaw member. The first and second apertures are configured to define a single aperture when the first and second jaw members are in a closed position. The first and second electrodes are configured to deliver energy.
Description
BACKGROUND

Electrosurgical devices are used in many surgical operations. Electrosurgical devices apply electrical energy to tissue in order to treat tissue. An electrosurgical device may comprise an instrument having a distally-mounted end effector comprising one or more electrodes. The end effector can be positioned against tissue such that electrical current is introduced into the tissue. Electrosurgical devices can be configured for bipolar or monopolar operation. During bipolar operation, current is introduced into and returned from the tissue by active and return electrodes, respectively, of the end effector. During monopolar operation, current is introduced into the tissue by an active (or source) electrode of the end effector and returned through a return electrode (e.g., a grounding pad) separately located on a patient's body. Heat generated by the current flow through the tissue may form hemostatic seals within the tissue and/or between tissues and thus may be particularly useful for sealing blood vessels, for example. The end effector of an electrosurgical device may further comprise a cutting member that is movable relative to the tissue and the electrodes to transect the tissue.


Electrical energy applied by an electrosurgical device can be transmitted to the instrument by a generator. The electrical energy may be in the form of radio frequency (“RF”) energy. RF energy is a form of electrical energy that may be in the frequency range of 100 kHz to 1 MHz. During its operation, an electrosurgical device can transmit low frequency RF energy through tissue, which causes ionic agitation, or friction, in effect resistive heating, thereby increasing the temperature of the tissue. Because a sharp boundary may be created between the affected tissue and the surrounding tissue, surgeons can operate with a high level of precision and control, without sacrificing un-targeted adjacent tissue. The low operating temperatures of RF energy may be useful for removing, shrinking, or sculpting soft tissue while simultaneously sealing blood vessels. RF energy may work particularly well on connective tissue, which is primarily comprised of collagen and shrinks when contacted by heat.


SUMMARY

In various embodiments, an end effector is disclosed. The end effector includes a first jaw member. The first jaw member comprises a first electrode. The first jaw member defines a first aperture at a distal end. The end effector includes a second jaw member. The second jaw member comprises a second electrode. The second jaw member defines a second aperture at a distal end. The second jaw member is operatively coupled to the first jaw member. The first and second apertures are configured to define a single aperture when the first and second jaw members are in a closed position. The first and second electrodes are configured to deliver energy.


In various embodiments, an end effector is disclosed. The end effector includes a first jaw member. The first jaw member comprises a first proximal contact surface and a first distal contact surface. The first proximal contact surface and the first distal contact surface define a first opening therebetween. The end effector includes a second jaw member comprising a second proximal contact surface and a second distal contact surface. The second jaw member is operatively coupled to the first jaw member. The second proximal contact surface and the second distal contact surface define a second opening therebetween. When the first and second jaw members are in a closed position, the first and second openings define an aperture. A first proximal electrode is coupled to the first proximal contact surface. The first proximal electrode is configured to deliver energy.


In various embodiments, an end effector is disclosed. The end effector includes a first jaw member operatively coupled to a second jaw member. The first and second jaw members each comprise a proximal contact region defined by a first width and a distal contact region defined by a second width. The first width is greater than the second width. A first electrode is coupled to the first jaw member. The first electrode is configured to deliver energy


In various embodiments, an end effector is disclosed. The end effector comprises a first jaw member. The first jaw member comprises a band electrode coupled to an outer surface of the first jaw member. The band electrode is configured to lay flush with the first jaw member in a first position. The band electrode is configured to flex outwardly from the first jaw member in a second position. The band electrode is configured to deliver energy. A second jaw member is operatively coupled to the first jaw member.





FIGURES

The features of the various embodiments are set forth with particularity in the appended claims. The various embodiments, however, both as to organization and methods of operation, together with advantages thereof, may best be understood by reference to the following description, taken in conjunction with the accompanying drawings as follows:



FIG. 1 illustrates a perspective view of one embodiment of an electrical energy surgical instrument.



FIG. 2 illustrates a side-view of a handle of one embodiment of the surgical instrument of FIG. 1 with a half of a handle body removed to illustrates some of the components therein.



FIG. 3 illustrates a perspective view of one embodiment of the end effector of the surgical instrument of FIG. 1 with the jaws open and the distal end of an axially movable member in a retracted position.



FIG. 4 illustrates a perspective view of one embodiment of the end effector of the surgical instrument of FIG. 1 with the jaws closed and the distal end of an axially moveable member in a partially advanced position.



FIG. 5 illustrates a perspective view of one embodiment of the axially moveable member of the surgical instrument of FIG. 1.



FIG. 6 illustrates a section view of one embodiment of the end effector of the surgical instrument of FIG. 1.



FIG. 7 illustrates a perspective view of one embodiment of a cordless electrical energy surgical instrument.



FIG. 8A illustrates a side view of a handle of one embodiment of the surgical instrument of FIG. 7 with half of the handle body removed to illustrate various components therein.



FIG. 8B illustrates one embodiment of an RF drive and control circuit.



FIG. 8C illustrates one embodiment of the main components of a control circuit.



FIG. 9 illustrates one embodiment of an end effector comprising an aperture.



FIG. 10 illustrates a perspective view of the end effector of FIG. 9.



FIG. 11 illustrates a top view of the end effector of FIG. 9.



FIG. 12 illustrates one embodiment of the end effector of FIG. 9 comprising a plurality of electrodes.



FIG. 13a illustrates one embodiment of the end effector of FIG. 9 coupled to an elongate shaft and in an open position.



FIG. 13b illustrates one embodiment of the end effector of FIG. 13a in a closed position.



FIG. 14 illustrates one embodiment of an end effector comprising a proximal grasping area and a distal grasping area and defining an aperture therebetween.



FIG. 15 illustrates a side view of the end effector of FIG. 14 in an open position.



FIG. 16 illustrates a side view of the end effector of FIG. 14 in a closed position.



FIG. 17 illustrates a perspective view of the end effector of FIG. 14 in a closed position.



FIG. 18 illustrates a top view of the end effector of FIG. 14.



FIG. 19A illustrates one embodiment of an end effector comprising a proximal grasping area and a distal grasping area, defining an aperture therebetween, in an open position.



FIG. 19B illustrates one embodiment of the end effector of FIG. 19A in a closed position.



FIG. 19C illustrates one embodiment of the end effector of FIG. 19A in a fired position.



FIG. 20 illustrates an exploded view of the end effector of FIG. 19A.



FIG. 21 illustrates one embodiment of an end effector comprising a proximal grasping area including a proximal electrode and a distal grasping area including a distal electrode.



FIG. 22 illustrates a top view of the end effector of FIG. 21.



FIG. 23 illustrates a perspective view of the end effector of FIG. 21.



FIG. 24 illustrates an exploded view of the end effector of FIG. 21.



FIG. 25 illustrates one embodiment of an end effector comprising a proximal contact region and a distal contact region.



FIG. 26 illustrates a top view of the end effector of FIG. 25.



FIG. 27 illustrates a side view of the end effector of FIG. 25 in an open position.



FIG. 28 illustrates a side view of the end effector of FIG. 25 in a closed position.



FIG. 29 illustrates one embodiment of an end effector comprising a proximal contact region and a distal contact region, the proximal and distal contact regions comprising a continuous electrode.



FIG. 30A illustrates one embodiment of an end effector comprising a proximal contact region and a distal contact region in an open position.



FIG. 30B illustrates the end effector of FIG. 30A in a closed position.



FIG. 30C illustrates the end effector of FIG. 30A in a fired position.



FIG. 31 illustrates an exploded view of the end effector of FIG. 30A.



FIG. 32 illustrates one embodiment of an end effector comprising a band electrode in a deployed position.



FIG. 33 illustrates the end effector of FIG. 32 in a retracted position.





DESCRIPTION

Reference will now be made in detail to several embodiments, including embodiments showing example implementations of electrosurgical medical instruments for cutting and coagulating tissue. Wherever practicable similar or like reference numbers may be used in the figures and may indicate similar or like functionality. The figures depict example embodiments of the disclosed surgical instruments and/or methods of use for purposes of illustration only. One skilled in the art will readily recognize from the following description that alternative example embodiments of the structures and methods illustrated herein may be employed without departing from the principles described herein.


Various embodiments of surgical instruments that utilize therapeutic and/or subtherapeutic electrical energy to treat tissue or provide feedback to the generators (e.g., electrosurgical instruments) are disclosed. The embodiments are adapted for use in a manual or hand-operated manner, although electrosurgical instruments may be utilized in robotic applications as well. FIG. 1 is a perspective view of one example embodiment of a surgical instrument system 100 comprising an electrical energy surgical instrument 110. The electrosurgical instrument 110 may comprise a proximal handle 112, a distal working end or end effector 126 and an introducer or elongated shaft 114 disposed in-between.


The electrosurgical system 100 can be configured to supply energy, such as electrical energy, ultrasonic energy, heat energy, or any combination thereof, to the tissue of a patient either independently or simultaneously, for example. In one example embodiment, the electrosurgical system 100 includes a generator 120 in electrical communication with the electrosurgical instrument 110. The generator 120 is connected to the electrosurgical instrument 110 via a suitable transmission medium such as a cable 122. In one example embodiment, the generator 120 is coupled to a controller, such as a control unit 125, for example. In various embodiments, the control unit 125 may be formed integrally with the generator 120 or may be provided as a separate circuit module or device electrically coupled to the generator 120 (shown in phantom to illustrate this option). Although in the presently disclosed embodiment, the generator 120 is shown separate from the electrosurgical instrument 110, in one example embodiment, the generator 120 (and/or the control unit 125) may be formed integrally with the electrosurgical instrument 110 to form a unitary electrosurgical system 100, where a battery located within the electrosurgical instrument 110 is the energy source and a circuit coupled to the battery produces the suitable electrical energy, ultrasonic energy, or heat energy. One such example is described herein below in connection with FIGS. 7-8C.


The generator 120 may comprise an input device 135 located on a front panel of the generator 120 console. The input device 135 may comprise any suitable device that generates signals suitable for programming the operation of the generator 120, such as a keyboard, or input port, for example. In one example embodiment, various electrodes in the first jaw 164a and the second jaw 164b may be coupled to the generator 120. The cable 122 may comprise multiple electrical conductors for the application of electrical energy to positive (+) and negative (−) electrodes of the electrosurgical instrument 110. The control unit 125 may be used to activate the generator 120, which may serve as an electrical source. In various embodiments, the generator 120 may comprise an RF source, an ultrasonic source, a direct current source, and/or any other suitable type of electrical energy source, for example, which may be activated independently or simultaneously.


In various embodiments, the electrosurgical system 100 may comprise at least one supply conductor 131 and at least one return conductor 133, wherein current can be supplied to the electrosurgical instrument 100 via the supply conductor 131 and wherein the current can flow back to the generator 120 via the return conductor 133. In various embodiments, the supply conductor 131 and the return conductor 133 may comprise insulated wires and/or any other suitable type of conductor. In certain embodiments, as described below, the supply conductor 131 and the return conductor 133 may be contained within and/or may comprise the cable 122 extending between, or at least partially between, the generator 120 and the end effector 126 of the electrosurgical instrument 110. In any event, the generator 120 can be configured to apply a sufficient voltage differential between the supply conductor 131 and the return conductor 133 such that sufficient current can be supplied to the end effector 126.



FIG. 2 is a side view of one example embodiment of the handle 112 of the surgical instrument 110. In FIG. 2, the handle 112 is shown with half of a first handle body 112a (see FIG. 1) removed to illustrate various components within the second handle body 112b. The handle 112 may comprise a lever arm 121 (e.g., a trigger) which may be pulled along a path 33. The lever arm 121 may be coupled to an axially moveable member 178 (FIGS. 3-6) disposed within the elongated shaft 114 by a shuttle 184 operably engaged to an extension 198 of lever arm 121. The shuttle 184 may further be connected to a biasing device, such as a spring 188, which may also be connected to the second handle body 112b, to bias the shuttle 184 and thus the axially moveable member 178 in a proximal direction, thereby urging the jaws 164a and 164b to an open position as seen in FIG. 1. Also, referring to FIGS. 1-2, a locking member 190 (see FIG. 2) may be moved by a locking switch 128 (see FIG. 1) between a locked position, where the shuttle 184 is substantially prevented from moving distally as illustrated, and an unlocked position, where the shuttle 184 may be allowed to freely move in the distal direction, toward the elongated shaft 114. The handle 112 can be any type of pistol-grip or other type of handle known in the art that is configured to carry actuator levers, triggers or sliders for actuating the first jaw 164a and the second jaw 164b. In some embodiments, the handle 112 may comprise a pencil-style handle. The elongated shaft 114 may have a cylindrical or rectangular cross-section, for example, and can comprise a thin-wall tubular sleeve that extends from handle 112. The elongated shaft 114 may include a bore extending therethrough for carrying actuator mechanisms, for example, the axially moveable member 178, for actuating the jaws and for carrying electrical leads for delivery of electrical energy to electrosurgical components of the end effector 126.


The end effector 126 may be adapted for capturing and transecting tissue and for contemporaneously welding the captured tissue with controlled application of energy (e.g., RF energy). The first jaw 164a and the second jaw 164b may close to thereby capture or engage tissue about a longitudinal axis “T” defined by the axially moveable member 178. The first jaw 164a and second jaw 164b may also apply compression to the tissue. In some embodiments, the elongated shaft 114, along with the first jaw 164a and second jaw 164b, can be rotated a full 360° degrees, as shown by the arrow 196 (see FIG. 1), relative to the handle 112. For example, a rotation knob 148 may be rotatable about the longitudinal axis of the shaft 114 and may be coupled to the shaft 114 such that rotation of the knob 148 causes corresponding rotation of the shaft 114. The first jaw 164a and the second jaw 164b can remain openable and/or closeable while rotated.



FIG. 3 shows a perspective view of one example embodiment of the end effector 126 with the jaws 164a, 164b open, while FIG. 4 shows a perspective view of one embodiment of the end effector 126 with the jaws 164a, 164b closed. As noted above, the end effector 126 may comprise the upper first jaw 164a and the lower second jaw 164b, which may be straight or curved. The first jaw 164a and the second jaw 164b may each comprise an elongated slot or channel 162a and 162b, respectively, disposed outwardly along their respective middle portions. Further, the first jaw 164a and the second jaw 164b may each have tissue-gripping elements, such as teeth 163, disposed on the inner portions of the first jaw 164a and the second jaw 164b. The first jaw 164a may comprise an upper first jaw body 162a with an upper first outward-facing surface and an upper first energy delivery surface 165a. The second jaw 164b may comprise a lower second jaw body 162b with a lower second outward-facing surface and a lower second energy delivery surface 165b. The first energy delivery surface 165a and the second energy delivery surface 165b may both extend in a “U” shape about the distal end of the end effector 126.


The lever arm 121 of the handle 112 (FIG. 2) may be adapted to actuate the axially moveable member 178, which also may function as a jaw-closing mechanism. For example, the axially moveable member 178 may be urged distally as the lever arm 121 is pulled proximally along the path 33 via the shuttle 184, as shown in FIG. 2 and discussed above. FIG. 5 is a perspective view of one example embodiment of the axially moveable member 178 of the surgical instrument 110. The axially moveable member 178 may comprise one or several pieces, but in any event, may be movable or translatable with respect to the elongated shaft 114 and/or the jaws 164a, 164b. Also, in at least one example embodiment, the axially moveable member 178 may be made of 17-4 precipitation hardened stainless steel. The distal end of axially moveable member 178 may comprise a flanged “I”-beam configured to slide within the channels 162a and 162b in jaws 164a and 164b. The axially moveable member 178 may slide within the channels 162a, 162b to open and close the first jaw 164a and the second jaw 164b. The distal end of the axially moveable member 178 may also comprise an upper flange or “c”-shaped portion 178a and a lower flange or “c”-shaped portion 178b. The flanges 178a, 178b respectively define inner cam surfaces 167a and 167b for engaging outward facing surfaces of the first jaw 164a and the second jaw 164b. The opening-closing of jaws 164a and 164b can apply very high compressive forces on tissue using cam mechanisms which may include movable “I-beam” axially moveable member 178 and the outward facing surfaces 169a, 169b of jaws 164a, 164b.


More specifically, referring now to FIGS. 3-5, collectively, the inner cam surfaces 167a and 167b of the distal end of axially moveable member 178 may be adapted to slideably engage the first outward-facing surface 369a and the second outward-facing surface 169b of the first jaw 164a and the second jaw 164b, respectively. The channel 162a within first jaw 164a and the channel 162b within the second jaw 164b may be sized and configured to accommodate the movement of the axially moveable member 178, which may comprise a tissue-cutting element 171, for example, comprising a sharp distal edge. FIG. 4, for example, shows the distal end of the axially moveable member 178 advanced at least partially through channels 162a and 162b (FIG. 3). The advancement of the axially moveable member 178 may close the end effector 126 from the open configuration shown in FIG. 3. In the closed position shown by FIG. 4, the upper first jaw 164a and the lower second jaw 164b define a gap or dimension D between the first energy delivery surface 165a and second energy delivery surface 165b of the first jaw 164a and the second jaw 164b, respectively. In various embodiments, dimension the D can equal from about 0.0005″ to about 0.040″, for example, and in some embodiments, between about 0.001″ to about 0.010″, for example. Also, the edges of the first energy delivery surface 165a and the second energy delivery surface 165b may be rounded to prevent the dissection of tissue.



FIG. 6 is a section view of one example embodiment of the end effector 126 of the surgical instrument 110. The engagement, tissue-contacting, surface 165b of the lower jaw 164b is adapted to deliver energy to tissue, at least in part, through a conductive-resistive matrix, such as a variable resistive PTC body, as discussed in more detail below. At least one of the upper and lower jaws 164a, 164b may carry at least one electrode 173 configured to deliver the energy from the generator 120 to the captured tissue. The engagement, tissue-contacting, surface 165a of the upper jaw 164a may carry a similar conductive-resistive matrix (i.e., a PTC material), or in some embodiments the surface may be a conductive electrode or an insulative layer, for example. Alternatively, the engagement surfaces of the jaws can carry any of the energy delivery components disclosed in U.S. Pat. No. 6,773,409, filed Oct. 22, 2001, entitled ELECTROSURGICAL JAW STRUCTURE FOR CONTROLLED ENERGY DELIVERY, the entire disclosure of which is incorporated herein by reference.


The first energy delivery surface 165a and the second energy delivery surface 165b each may be in electrical communication with the generator 120. The first energy delivery surface 165a and the second energy delivery surface 165b may be configured to contact tissue and deliver electrosurgical energy to captured tissue which are adapted to seal or weld the tissue. The control unit 125 regulates the electrical energy delivered by electrical generator 120 which in turn delivers electrosurgical energy to the first energy delivery surface 165a and the second energy delivery surface 165b. The energy delivery may be initiated by an activation button 128 (FIG. 2) operably engaged with the lever arm 121 and in electrical communication with the generator 120 via a cable 122. In one example embodiment, the electrosurgical instrument 110 may be energized by the generator 120 by way of a foot switch 129 (FIG. 1). When actuated, the foot switch 129 triggers the generator 120 to deliver electrical energy to the end effector 126, for example. The control unit 125 may regulate the power generated by the generator 120 during activation. Although the foot switch 129 may be suitable in many circumstances, other suitable types of switches can be used, such as, for example, a thumb switch.


As mentioned above, the electrosurgical energy delivered by electrical generator 120 and regulated, or otherwise controlled, by the control unit 125 may comprise radio frequency (RF) energy, or other suitable forms of electrical energy. Further, the opposing first and second energy delivery surfaces 165a and 165b may carry variable resistive PTC bodies that are in electrical communication with the generator 120 and the control unit 125. Additional details regarding electrosurgical end effectors, jaw closing mechanisms, and electrosurgical energy-delivery surfaces are described in the following U.S. patents and published patent applications: U.S. Pat. Nos. 7,087,054; 7,083,619; 7,070,597; 7,041,102; 7,011,657; 6,929,644; 6,926,716; 6,913,579; 6,905,497; 6,802,843; 6,770,072; 6,656,177; 6,533,784; and 6,500,112; and U.S. Pat. App. Pub. Nos. 2010/0036370 and 2009/0076506, all of which are incorporated herein by reference in their entirety and made part of this specification.


In one example embodiment, the generator 120 may be implemented as an electrosurgery unit (ESU) capable of supplying power sufficient to perform bipolar electrosurgery using radio frequency (RF) energy. In one example embodiment, the ESU can be a bipolar ERBE ICC 150 sold by ERBE USA, Inc. of Marietta, Ga. In some embodiments, such as for bipolar electrosurgery applications, a surgical instrument having an active electrode and a return electrode can be utilized, wherein the active electrode and the return electrode can be positioned against, adjacent to and/or in electrical communication with, the tissue to be treated such that current can flow from the active electrode, through the PTC bodies and to the return electrode through the tissue. Thus, in various embodiments, the electrosurgical system 100 may comprise a supply path and a return path, wherein the captured tissue being treated completes, or closes, the circuit. In one example embodiment, the generator 120 may be a monopolar RF ESU and the electrosurgical instrument 110 may comprise a monopolar end effector 126 in which one or more active electrodes are integrated. For such a system, the generator 120 may require a return pad in intimate contact with the patient at a location remote from the operative site and/or other suitable return path. The return pad may be connected via a cable to the generator 120. In other embodiments, the operator may provide subtherapeutic RF energy levels for purposes of evaluating tissue conditions and providing feedback in the electrosurgical system 100. Such feed back may be employed to control the therapeutic RF energy output of the electrosurgical instrument 110.


During operation of electrosurgical instrument 100, the user generally grasps tissue, supplies energy to the grasped tissue to form a weld or a seal (e.g., by actuating button 128 and/or pedal 129), and then drives a tissue-cutting element 171 at the distal end of the axially moveable member 178 through the grasped tissue. According to various embodiments, the translation of the axial movement of the axially moveable member 178 may be paced, or otherwise controlled, to aid in driving the axially moveable member 178 at a suitable rate of travel. By controlling the rate of the travel, the likelihood that the captured tissue has been properly and functionally sealed prior to transection with the cutting element 171 is increased.



FIG. 7 is a perspective view of one example embodiment of a surgical instrument system 200 comprising a cordless electrical energy surgical instrument 210. The electrosurgical system 200 is similar to the electrosurgical system 100. The electrosurgical system 200 can be configured to supply energy, such as electrical energy, ultrasonic energy, heat energy, or any combination thereof, to the tissue of a patient either independently or simultaneously as described in connection with FIG. 1, for example. The electrosurgical instrument 210 may utilize the end effector 126 and elongated shaft 114 described here in conjunction with a cordless proximal handle 212. In one example embodiment, the handle 212 includes a generator circuit 220 (see FIG. 8A). The generator circuit 220 performs a function substantially similar to that of generator 120. In one example embodiment, the generator circuit 220 is coupled to a controller, such as a control circuit. In the illustrated embodiment, the control circuit is integrated into the generator circuit 220. In other embodiments, the control circuit may be separate from the generator circuit 220.


In one example embodiment, various electrodes in the end effector 126 (including the first and second jaws 164a, 164b thereof) may be coupled to the generator circuit 220. The control circuit may be used to activate the generator 220, which may serve as an electrical source. In various embodiments, the generator 220 may comprise an RF source, an ultrasonic source, a direct current source, and/or any other suitable type of electrical energy source, for example. In one example embodiment, a button 128 may be provided to activate the generator circuit 220 to provide energy to the end effector 126.



FIG. 8A is a side view of one example embodiment of the handle 212 of the cordless surgical instrument 210. In FIG. 8A, the handle 212 is shown with half of a first handle body removed to illustrate various components within the second handle body 234. The handle 212 may comprise a lever arm 224 (e.g., a trigger) which may be pulled along a path 33 around a pivot point. The lever arm 224 may be coupled to an axially moveable member 278 disposed within the elongated shaft 114 by a shuttle operably engaged to an extension of lever arm 221. In one example embodiment, the lever arm 221 defines a shepherd's hook shape comprising a distal trigger hook 221a and a proximal trigger portion 221b. As illustrated, the distal trigger hook 221a may have a first length while the proximal trigger portion 221b may have a second length with the second length greater than the first length.


In one example embodiment, the cordless electrosurgical instrument comprises a battery 237. The battery 237 provides electrical energy to the generator circuit 220. The battery 237 may be any battery suitable for driving the generator circuit 220 at the desired energy levels. In one example embodiment, the battery 237 is a 1030 mAhr, triple-cell Lithium Ion Polymer battery. The battery may be fully charged prior to use in a surgical procedure, and may hold a voltage of about 12.6V. The battery 237 may have two fuses fitted to the cordless electrosurgical instrument 210, arranged in line with each battery terminal. In one example embodiment, a charging port 239 is provided to connect the battery 237 to a DC current source (not shown).


The generator circuit 220 may be configured in any suitable manner. In some embodiments, the generator circuit comprises an RF drive and control circuit 240 and a controller circuit 282. FIG. 8B illustrates an RF drive and control circuit 240, according to one embodiment. FIG. 8B is a part schematic part block diagram illustrating the RF drive and control circuitry 240 used in this embodiment to generate and control the RF electrical energy supplied to the end effector 126. As will be explained in more detail below, in this embodiment, the drive circuitry 240 is a resonant mode RF amplifier comprising a parallel resonant network on the RF amplifier output and the control circuitry operates to control the operating frequency of the drive signal so that it is maintained at the resonant frequency of the drive circuit, which in turn controls the amount of power supplied to the end effector 126. The way that this is achieved will become apparent from the following description.


As shown in FIG. 8B, the RF drive and control circuit 240 comprises the above described battery 237 are arranged to supply, in this example, about 0V and about 12V rails. An input capacitor (Cin) 242 is connected between the 0V and the 12V for providing a low source impedance. A pair of FET switches 243-1 and 243-2 (both of which are N-channel in this embodiment to reduce power losses) is connected in series between the 0V rail and the 12V rail. FET gate drive circuitry 245 is provided that generates two drive signals—one for driving each of the two FETs 243. The FET gate drive circuitry 245 generates drive signals that causes the upper FET (243-1) to be on when the lower FET (243-2) is off and vice versa. This causes the node 247 to be alternately connected to the 12V rail (when the FET 243-1 is switched on) and the 0V rail (when the FET 243-2 is switched on). FIG. 8B also shows the internal parasitic diodes 248-1 and 248-2 of the corresponding FETs 243, which conduct during any periods that the FETs 243 are open.


As shown in FIG. 8B, the node 247 is connected to an inductor-inductor resonant circuit 250 formed by inductor Ls 252 and inductor Lm 254. The FET gate driving circuitry 245 is arranged to generate drive signals at a drive frequency (fd) that opens and crosses the FET switches 243 at the resonant frequency of the parallel resonant circuit 250. As a result of the resonant characteristic of the resonant circuit 250, the square wave voltage at node 247 will cause a substantially sinusoidal current at the drive frequency (fd) to flow within the resonant circuit 250. As illustrated in FIG. 8B, the inductor Lm 254 is the primary of a transformer 255, the secondary of which is formed by inductor Lsec 256. The inductor Lsec 256 of the transformer 255 secondary is connected to an inductor-capacitor-capacitor parallel resonant circuit 257 formed by inductor L2 258, capacitor C4 260, and capacitor C2 262. The transformer 255 up-converts the drive voltage (Vd) across the inductor Lm 254 to the voltage that is applied to the output parallel resonant circuit 257. The load voltage (VL) is output by the parallel resonant circuit 257 and is applied to the load (represented by the load resistance Rload 259 in FIG. 8B) corresponding to the impedance of the forceps' jaws and any tissue or vessel gripped by the end effector 126. As shown in FIG. 8B, a pair of DC blocking capacitors Cbl 280-1 and 280-2 is provided to prevent any DC signal being applied to the load 259.


In one embodiment, the transformer 255 may be implemented with a Core Diameter (mm), Wire Diameter (mm), and Gap between secondary windings in accordance with the following specifications:


Core Diameter, D (mm)

D=19.9×10−3


Wire diameter, W (mm) for 22 AWG wire

W=7.366×10−4


Gap between secondary windings, in gap=0.125

G=gap/25.4


In this embodiment, the amount of electrical power supplied to the end effector 126 is controlled by varying the frequency of the switching signals used to switch the FETs 243. This works because the resonant circuit 250 acts as a frequency dependent (loss less) attenuator. The closer the drive signal is to the resonant frequency of the resonant circuit 250, the less the drive signal is attenuated. Similarly, as the frequency of the drive signal is moved away from the resonant frequency of the circuit 250, the more the drive signal is attenuated and so the power supplied to the load reduces. In this embodiment, the frequency of the switching signals generated by the FET gate drive circuitry 245 is controlled by a controller 281 based on a desired power to be delivered to the load 259 and measurements of the load voltage (VL) and of the load current (IL) obtained by conventional voltage sensing circuitry 283 and current sensing circuitry 285. The way that the controller 281 operates will be described in more detail below.


In one embodiment, the voltage sensing circuitry 283 and the current sensing circuitry 285 may be implemented with high bandwidth, high speed rail-to-rail amplifiers (e.g., LMH6643 by National Semiconductor). Such amplifiers, however, consume a relatively high current when they are operational. Accordingly, a power save circuit may be provided to reduce the supply voltage of the amplifiers when they are not being used in the voltage sensing circuitry 283 and the current sensing circuitry 285. In one-embodiment, a step-down regulator (e.g., LT1502 by Linear Technologies) may be employed by the power save circuit to reduce the supply voltage of the rail-to-rail amplifiers and thus extend the life of the battery 237.



FIG. 8C illustrates the main components of the controller 281, according to one embodiment. In the embodiment illustrated in FIG. 8C, the controller 281 is a microprocessor based controller and so most of the components illustrated in FIG. 8C are software based components. Nevertheless, a hardware based controller 281 may be used instead. As shown, the controller 281 includes synchronous I,Q sampling circuitry 291 that receives the sensed voltage and current signals from the sensing circuitry 283 and 285 and obtains corresponding samples which are passed to a power, Vrms and Irms calculation module 293. The calculation module 293 uses the received samples to calculate the RMS voltage and RMS current applied to the load 259 (FIG. 8B; end effector 126 and tissue/vessel gripped thereby) and from them the power that is presently being supplied to the load 259. The determined values are then passed to a frequency control module 295 and a medical device control module 297. The medical device control module 297 uses the values to determine the present impedance of the load 259 and based on this determined impedance and a pre-defined algorithm, determines what set point power (Pset) should be applied to the frequency control module 295. The medical device control module 297 is in turn controlled by signals received from a user input module 299 that receives inputs from the user (for example pressing buttons or activating the control levers 114, 110 on the handle 104) and also controls output devices (lights, a display, speaker or the like) on the handle 104 via a user output module 261.


The frequency control module 295 uses the values obtained from the calculation module 293 and the power set point (Pset) obtained from the medical device control module 297 and predefined system limits (to be explained below), to determine whether or not to increase or decrease the applied frequency. The result of this decision is then passed to a square wave generation module 263 which, in this embodiment, increments or decrements the frequency of a square wave signal that it generates by 1 kHz, depending on the received decision. As those skilled in the art will appreciate, in an alternative embodiment, the frequency control module 295 may determine not only whether to increase or decrease the frequency, but also the amount of frequency change required. In this case, the square wave generation module 263 would generate the corresponding square wave signal with the desired frequency shift. In this embodiment, the square wave signal generated by the square wave generation module 263 is output to the FET gate drive circuitry 245, which amplifies the signal and then applies it to the FET 243-1. The FET gate drive circuitry 245 also inverts the signal applied to the FET 243-1 and applies the inverted signal to the FET 243-2.


The electrosurgical instrument 210 may comprise additional features as discussed with respect to the electrosurgical system 100 illustrated in FIGS. 1-6. Those skilled in the art will recognize that electrosurgical instrument 210 may include a rotation knob 148, an elongated shaft 114, and an end effector 126. These elements function in a substantially similar manner to that discussed above with respect to the electrosurgical system 100 illustrated in FIGS. 1-6. In one example embodiment, the cordless electrosurgical instrument 210 may include visual indicators 235. The visual indicators 235 may provide a visual indication signal to an operator. In one example embodiment, the visual indication signal may alert an operator that the device is on, or that the device is applying energy to the end effector. Those skilled in the art will recognize that the visual indicators 235 may be configured to provide information on multiple states of the device.



FIG. 9 illustrates one embodiment of an end effector 326 comprising an aperture. The end effector 326 is configured for use with an electrosurgical instrument, such as, for example, the electrosurgical instruments 110, 210 illustrated in FIGS. 1-8C. The end effector 326 comprises a first jaw member 364a and a second jaw member 364b. The first jaw member 364a comprises a first aperture 366a defined by the distal portion of the first jaw member 364a. The second jaw member 364b comprises a second aperture 366b defined by the distal portion of the second jaw member 364b. The end effector 326 is similar to the end effector 126 illustrated in FIGS. 3-5. For example, the end effector 326 may comprise one or more staples 363, I-beam channels 362a, 362b formed on both the first and second jaws 364a, 364b, and/or a cutting instrument (see FIG. 11) deployable within the channels 362a, 362b.



FIG. 10 illustrates the end effector 326 in a closed position. The end effector 326 is transitioned from an open position, as shown in FIG. 9, to the closed position shown in FIG. 10 by, for example, actuating one or more levers on the handle 112. When the end effector 326 is in a closed position, the first aperture 366a and the second aperture 366b align to define a single aperture 366. The aperture 366 provides improved tip grasping to the end effector 326. FIG. 11 illustrates a top-down view of the end effector 326. The distal end of the end effector 326 defining the aperture 366 is configured to grasp a material, such as, for example, tissue, before, during, and after application of energy, such as, for example, electrosurgical and/or ultrasonic energy. The end effector 326 may be referred to as a fenestrated end effector.



FIG. 11 illustrates a top view of the end effector 326 of FIG. 9. The first channel 362a and the second channel 362b align to define a longitudinal channel 362. A cutting member 371 is slideably receivable within the longitudinal channel 362. The cutting member 371 is deployable to cut tissue and/or other materials located between the first jaw member 364a and the second jaw member 364b. In some embodiments, the cutting member 371 comprises an I-Beam. FIG. 11 illustrates the alignment of the first aperture 366a and the second aperture 366b to define a single aperture 366. In some embodiments, the end effector 326 comprises a width suitable for insertion through a trocar. For example, the end effector may comprise a width of about 4.50 millimeters.



FIG. 12 illustrates one embodiment of the end effector 326 comprising energy deliver surfaces, such as, for example, a first electrode 365a and a second electrode 365b. The electrodes 365a, 365b are configured to deliver energy to a tissue section grasped between the first jaw member 364a and the second jaw member 364b. The electrodes 365a, 365b may be configured to provide monopolar RF energy, bipolar RF energy, ultrasonic energy, or any combination thereof to a tissue section. In some embodiments, the electrodes 365a, 365b are configured as source electrodes and are coupled to a generator 120, for example, through a supply conductor 131. The second jaw member 364b and/or a second contact surface 365c in the second jaw member 364b may be configured as a return electrode coupled to the generator 120 through a return conductor 133. In some embodiments, the energy contact surfaces 365a-365c comprise a positive temperature coefficient (PTC) material. The PTC material may limit the energy delivered by the energy contact surfaces 365a-365c as the temperature of the energy contact surfaces 365a-365c increases during treatment. The energy contact surfaces 365a-365c may be configured to provide therapeutic RF energy, subtherapeutic RF energy, ultrasonic energy, or any combination thereof.



FIG. 13A illustrates one embodiment of the end effector 326 coupled to an elongate shaft 314. The end effector 326 is shown in an open position. An actuator within the elongate shaft 314 is configured to transition the end effector 326 from an open position, shown in FIG. 13a, to a closed position, as shown in FIG. 13B. In one embodiment, one or more actuators extend through the shaft 314. The one or more actuators are configured to transition the first and second jaws 364a, 364b of the end effector 326 from an open position to a closed position. In one embodiment, the one or more actuators are coupled to one or more actuation handles 368a, 368b. A first actuation handle 368a is moved from a first position, shown in FIG. 13A, to a second position, shown in FIG. 13B. The movement of the first actuation handle 368a causes the first jaw member 364a to transition to a closed position. A second actuator handle 368b may be configured, for example, to advance a cutting instrument 371 into the longitudinal channel 362.


In operation, the end effector 326 is positioned by a surgeon at a surgical site. The end effector 326 is positioned through, for example, endoscopic, laparoscopic, or open surgery techniques. A surgeon positions a tissue section between the first jaw member 364a and the second jaw member 364b. The surgeon operates an actuator, such as, for example, a trigger coupled to handle or a first actuation ring 368a coupled to the elongate shaft 314, to cause the first jaw member 364a to rotate or transition to a closed position to grasp the tissue section between the first jaw member 364a and the second jaw member 364b. In some embodiments, the end effector 326 comprises an energy delivery surface, such as, for example, one or more electrodes 365a, 365b configured to deliver energy. The surgeon may activate delivery of energy to the electrodes 365a, 365b. The electrodes 365a, 365b deliver the energy to the tissue section grasped between the first jaw member 364a and the second jaw member 364b. The delivered energy may weld, cauterize, dissect, and/or otherwise treat the tissue section. In some embodiments, the first jaw member 364a defines a first channel 362a and the second jaw member 364b defines a second channel 362b. The first and second channels 362a, 362b define a longitudinal channel 362. A cutting member 371 is slideably receivable within the longitudinal channel 362. The cutting member 371 is deployable to cut the tissue section before, during, or after treatment of the tissue.



FIG. 14 illustrates one embodiment of an end effector 426 comprising a proximal grasping area and a distal grasping area. The end effector 426 comprises a first jaw member 464a and a second jaw member 464b. The first and second jaw members 464a, 464b are operable to grasp tissue and/or other materials therebetween. The end effector 426 is configured to provide atraumatic grasping. The first jaw member 464a comprises a first proximal contact surface 465a and a first distal contact surface 467a. The first proximal contact surface 465a and the first distal contact surface 467a define a first opening 466a therebetween. The second jaw member 464b comprises a second proximal contact surface 465b and a second distal contact surface 467b. The second proximal contact surface 465b and the second distal contact surface 467b define a second opening 466b therebetween. When the first and second jaw members 464a, 464b are in a closed position, the first and second openings 466a, 466b define an aperture 466. The aperture 466 is configured to receive tissue therein. The aperture 466 provides atraumatic grasping. The end effector 426 may be referred to as a Babcock end effector.


The proximal contact surfaces 465a, 465b are located in the proximal portions of respective first and second jaw members 464a, 464b and define a proximal grasping area 469. In some embodiments, the proximal contact surfaces 465a, 465b comprise an energy delivery surface configured to deliver energy. The proximal contact surfaces 465a, 465b may be configured to provide monopolar RF energy, bipolar RF energy, ultrasonic energy, or any combination thereof to a tissue section grasped between the first jaw member 464a and the second jaw member 464b. The proximal contact surfaces 465a, 465b define a longitudinal channel 462. A cutting member 471 (see FIG. 18) is slideably received within the channel 462. The cutting member 471 is deployable within the longitudinal channel 462 to cut tissue grasped between the proximal contact surfaces 465a, 465b.



FIGS. 15-18 illustrate various views of the end effector 426 comprising a proximal grasping area 469 and a distal grasping area 470. FIG. 16 illustrates the end effector 426 in a closed position. The first opening 466a and the second opening 466b align when the end effector 426 is in a closed position to define the aperture 466. The proximal grasping area 469 is located proximally of the aperture 466 and the distal grasping area 470 is located distally of the aperture 466. Grasping tissue with the distal grasping area 470 reduces the surface area of tissue that is grasped and provides for atruamatic grasping. FIGS. 17 and 18 illustrate a top view of the end effector 426. A longitudinal channel 462 is configured to slideably receive a cutting member 471 therein. In the illustrated embodiment, the longitudinal channel 462 extends along the proximal grasping area 469 and does not extend into the aperture 466 or the distal grasping area 470. Cutting of tissue is therefore limited to tissue grasped within the proximal grasping area.


In some embodiments, the first proximal contact surface 465a and/or the second proximal contact surface 465b comprise energy delivery surfaces. The energy deliver surfaces 465a, 465b are configured to deliver energy. The energy delivery surfaces 465a, 465b comprise, for example, one or more electrodes. The energy deliver surfaces 465a, 465b may be configured to deliver monopolar RF energy, bipolar RF energy, ultrasonic energy, or any combination thereof to a tissue section grasped between the first and second jaw members 464a, 464b. The delivered energy may comprise a therapeutic signal configured to seal or weld the tissue section and/or a subtherapeutic signal. In some embodiments, the first proximal contact surface 465a and/or the second proximal contact surface 465b comprise a PTC material configured to limit the delivered energy as the temperature of the treated tissue increases. In some embodiments, the first proximal contact surface 465a and/or the second proximal contact surface 465b may comprise a metal contact electrode and/or an insulative layer.


In various embodiments, the distal contact surfaces 467a, 467b define a distal grasping area 470. The distal grasping area 470 is configured to provide atraumatic grasping. An aperture 466 is defined between the proximal grasping area 469 and the distal grasping area 470. The distal grasping area 470 and the aperture 466 enable the grasping of a tissue section atraumatically. In some embodiments, the distal grasping area 470 is configured to deliver electrosurgical energy to a tissue section grasped therein. In other embodiments, the distal grasping area 470 is electrically inactive.



FIG. 19A illustrates one embodiment of the end effector 426 comprising a proximal grasping area and a distal grasping area coupled to an elongate shaft 414. In operation, the end effector 426 is positioned with a tissue section, or other material, located between the first jaw member 464a and the second jaw member 464b. The first jaw member 464a is pivoted to a closed position, as shown in FIG. 19B, to grasp tissue between the first jaw member 464a and the second jaw member 464b. The first jaw member 464a may be pivoted by, for example, actuating a trigger on a handle coupled to the elongate shaft 414 or an actuation ring 468a coupled to the elongate shaft 414. Tissue may be grasped by the proximal grasping area 469, the distal grasping area 470, or both the proximal grasping area 469 and the distal grasping area 470. In some embodiments, the proximal grasping area 469 is configured to treat tissue grasped within the proximal grasping area 469, for example, by delivering energy, stapling, and/or cutting a tissue section grasped in the proximal grasping area. FIG. 19C illustrates the end effector 426 in a fired position. In some embodiments, a cutting instrument 471 is slideably receivable within the longitudinal channel 462 defined by the first and second jaw members 464a, 464b. The cutting instrument 471 is deployable by, for example, advancing a second actuation ring 468b. The second actuation ring 468b causes the cutting instrument 471 to traverse the longitudinal channel 462 and to cut tissue grasped therein.



FIG. 20 illustrates an exploded view of the end effector 426 and elongate shaft 414. As illustrated in FIG. 20, the end effector 426 comprises a first jaw member 464a and a second jaw member 464b. A plurality of electrodes 465a, 465c are coupled to the first jaw member 464a to define a proximal energy delivery surface. A source conductor 431 couples the plurality of electrode 465a, 465c to a generator (not shown). A return electrode 465b is coupled to the second jaw member 464b. A return conductor 433 couples the return electrode 465b to the generator. An actuator 424 is coupled to first jaw member 464a to pivot the first jaw member 464a from an open position to a closed position.



FIGS. 21-24 illustrate one embodiment of an end effector 526 comprising a proximal grasping area configured to deliver energy and a distal grasping area configured to deliver energy. A first jaw member 564a comprises a first proximal contact area 565a and a first distal contact area 567a. The first proximal contact area 565a and the first distal contact area 567a define a first opening 566a therebetween. A second jaw member 564b comprises a second proximal contact area 565b and a second distal contact area 567b. The second proximal contact area 565b and the second distal contact area 567b define a second opening 566b therebetween. The first and second openings 566a, 566b define an aperture 566 when the first jaw member 564a and the second jaw member 564b are in a closed position. The first and second proximal contact areas 565a, 565b define a proximal grasping area 569 and the first and second distal contact areas 567a, 567b define a distal grasping area 570.


In some embodiments, the first proximal contact surface 565a and/or the second proximal contact surface 565b comprise energy deliver surfaces. The energy delivery surfaces 565a, 565b are configured to deliver energy. The energy delivery surfaces 565a, 565b may be configured to deliver monopolar RF energy, bipolar RF energy, ultrasonic energy, or any combination thereof to a tissue section grasped between the first and second jaw members 564a, 564b. The delivered energy may comprise a therapeutic signal configured to seal or weld the tissue section and/or a sub-therapeutic signal. In some embodiments, the first proximal contact surface 565a and/or the second proximal contact surface 565b comprise a PTC material configured to limit the delivered energy as the temperature of the treated tissue increases. In some embodiments, the first proximal contact surface 565a and/or the second proximal contact surface 565b may comprise a metal contact electrode and/or an insulative layer. In some embodiments, the first proximal contact surface 565a and/or the second proximal contact surface 565b may comprise a return electrode.


In various embodiments, the distal contact surfaces 567a, 567b define a distal grasping area 570. The distal grasping area 570 is configured to provide atraumatic grasping. An aperture 566 is defined between the proximal grasping area 569 and the distal grasping area 570. The distal grasping area 570 and the aperture 566 enable the grasping of a tissue section atraumatically. In some embodiments, the distal grasping area 570 is configured to deliver electrosurgical energy to a tissue section grasped therein. In other embodiments, the distal grasping area 570 is electrically inactive.


In some embodiments, the first distal contact surface 567a and/or the second distal contact surface 567b comprise energy delivery surfaces, such as, for example, one or more electrodes. The distal energy delivery surfaces 567a, 567b are configured to deliver energy. Energy is delivered to a tissue section grasped within distal grasping area 570. The distal energy delivery surfaces 567a, 567b may be configured to deliver monopolar RF energy, bipolar RF energy, ultrasonic energy, or any combination thereof. The distal energy delivery surfaces 667a, 667b may be configured to provide a therapeutic signal configured to weld or seal a tissue section and/or a sub-therapeutic signal. In some embodiments, the distal grasping area 570 enables an operator to spot weld and/or perform touch-up cauterization after general treatment by the proximal grasping area 569.


In some embodiments, the proximal grasping area 569 and the distal grasping area 570 comprise energy delivery surfaces. The proximal energy deliver surfaces 565a, 565b are operable independently of the distal energy delivery surfaces 567a, 567b. For example, in some embodiments, a handle, such as the handle 112 shown in FIG. 1, comprises a first button for controlling delivery of energy to the proximal grasping area 569 and a second button for controlling delivery of energy to the distal grasping area 570. In other embodiments, a single button is configured to control delivery of energy to both the proximal grasping area 569 and the distal grasping area 570.


With reference now to FIG. 22, in some embodiments, the first jaw member 564a and the second jaw member 564b define a longitudinal channel 562. A cutting instrument 571 is slideably receivable within the longitudinal channel 562. The cutting instrument 571 is deployable to cut tissue grasped within the proximal grasping area 569. In the illustrated embodiment, the longitudinal channel 562 extends along the length of the proximal grasping area 569, but does not extend into the aperture 566. Therefore, cutting of tissue is limited to tissue grasped in the proximal grasping area 569.


As shown in FIG. 23, in some embodiments, the first proximal contact area 565a comprises a first electrode 572a and a second electrode 572b. The first and second electrodes 572a, 572b are configured to deliver energy. The first and second electrodes 572a, 572b are configured to deliver energy to, for example, a tissue section grasped within the proximal grasping area 569. In one embodiment, the first electrode 572a comprises a source electrode and the second electrode 572b comprises a return electrode. In other embodiments, the first and second electrodes 572a, 572b both comprise source electrodes. The second proximal contact area 565b is configured as a return electrode. In some embodiments, the first and second electrodes 572a, 572b comprise a PTC material.



FIG. 24 illustrates an exploded view of the end effector 526 and elongate shaft 514. As illustrated in FIG. 24, the end effector 526 comprises a first jaw member 564a and a second jaw member 564b. A plurality of electrodes 565a, 565c are coupled to the first jaw member 564a to define a proximal energy delivery surface. A source conductor 531 couples the plurality of electrode 565a, 565c to a generator (not shown). A return electrode 565b is coupled to the second jaw member 564b. A return conductor 533 couples the return electrode 565b to the generator. An actuator 524 is coupled to first jaw member 564a to pivot the first jaw member 564a from an open position to a closed position.



FIGS. 25-28 illustrate one embodiment of an end effector 626 comprising a proximal contact region and a distal contact region. The end effector 626 comprises a first jaw member 664a and a second jaw member 664b. The first jaw member 664a comprises a first proximal contact region 665a and a first distal contact region 667a. The second jaw member 664b comprises a second proximal contact region 665b and a second distal contact region 667b. The first and second proximal contact regions 665a, 665b comprise a first width. The first and second distal contact regions 667a, 667b comprise a second width. The first width is greater than the second width. The proximal contact regions 665a, 665b of the first and second jaw members 664a, 664b provide a contact region for grasping large sections of tissue. The distal contact regions 667a, 667b of the first and second jaw members 664a, 664b provide a contact region for grasping and treating smaller sections of tissue. In some embodiments, the distal contact regions 667a, 667b may comprise a hook shape. The smaller width of the distal contact regions 667a, 667b allows a surgeon to manipulate the end effector 626 to treat difficult to reach tissue sections and/or to apply energy to a smaller tissue section as compared to the proximal contact regions 665a, 665b. For example, in one embodiment, the first width is about 5.0 mm and the second width is about 3.0 mm, allowing a surgeon to access smaller areas not easily accessible by a 5.0 mm surgical instrument.



FIG. 26 illustrates a top view of the end effector 626. The first jaw member 646a and the second jaw member 664b define a longitudinal channel 662. A cutting member 671 is slideably receivable within the longitudinal channel 662. The cutting member 671 may comprise, for example, an I-beam. The cutting member 671 is deployable to cut tissue grasped between the first and second jaw members 664a, 664b. In some embodiments, the cutting member 671 comprises an ultrasonic blade. In the illustrated embodiment, the longitudinal channel 662 extends through both the proximal grasping area 669 and the distal grasping area 670, enabling the cutting member 671 to cut tissue grasped in both the proximal grasping area 669 and the distal grasping area 670.



FIG. 29 illustrates a perspective view of the end effector 626. In some embodiments, the end effector 626 comprises one or more continuous electrodes 666. The continuous electrode 666 is configured to provide energy to a tissue section grasped between the first jaw member 664a and the second jaw member 664b. The continuous electrode 666 extends over the first proximal contact area 665a and the first distal contact area 667a. The continuous electrode 666 is configured to provide energy to tissue grasped between any section of the first and second jaw members 664a, 664b. In some embodiments, the continuous electrode 666 comprises a monopolar electrode. In other embodiments, the continuous electrode 666 comprises a bi-polar electrode. The second jaw member 664b may comprise a return electrode (not shown). The continuous electrode 666 may be configured to deliver therapeutic RF energy, subtherapeutic RF energy, ultrasonic energy, or any combination thereof.



FIGS. 30A-30C illustrate operation of the end effector 626. The end effector 626 is coupled to an elongate shaft 614. FIG. 30A illustrates the first jaw member 664a and the second jaw member 664b in an open position. In operation, the end effector 626 is positioned by a surgeon at a surgical site. The end effector 626 is positioned through, for example, endoscopic, laparoscopic, or open surgery techniques. A surgeon positions a tissue section between the first jaw member 664a and the second jaw member 664b. The surgeon operates a second actuation handle 668b to cause the first jaw member 664a to rotate or transition to a closed position to grasp the tissue section between the first jaw member 664a and the second jaw member 664b, as illustrated in FIG. 30B. Tissue may be grasped between the proximal contact areas 665a, 665b, the distal contact areas 667a, 667b, or both. In some embodiments, the end effector 626 comprises one or more continuous electrodes 666 configured to deliver energy. The surgeon may activate delivery of energy to the electrodes 666. The continuous electrode 666 delivers the energy to the tissue section grasped between the first jaw member 664a and the second jaw member 664b. The delivered energy may weld, cauterize, dissect, and/or otherwise treat the tissue section. In some embodiments, the first jaw member 664a and the second jaw member 664b define a longitudinal channel 662. A cutting member 671 is slideably receivable within the longitudinal channel 662. The cutting member 671 is deployable to cut the tissue section. The cutting member 671 may be deployed, for example, by sliding a first actuation handle 668a distally, causing the cutting member 671 to slideably, distally advance into the longitudinal channel 662. FIG. 30C illustrates the end effector 626 in a fired position, in which the cutting member 671 has been advanced to the distal end of the longitudinal channel 662.



FIG. 31 illustrates an exploded view of the end effector 626 and elongate shaft 614. As illustrated in FIG. 31, the end effector 626 comprises a first jaw member 664a and a second jaw member 664b. A continuous electrode 666 is coupled to the first jaw member 664a to define a proximal energy delivery surface. A source conductor 631 couples the continuous electrode 666 to a generator (not shown). A return electrode 665 is coupled to the second jaw member 664b. A return conductor 633 couples the return electrode 665 to the generator. An actuator 624 is coupled to first jaw member 664a to pivot the first jaw member 664a from an open position to a closed position.



FIG. 32 illustrates one embodiment of an end effector 726 comprising band electrode 766. The end effector 726 comprises a first jaw member 764a and a second jaw member 764b. A band electrode 766 is coupled to an outer surface of the first jaw member 764a. The band electrode 766 may be coupled, for example, to a top portion of the first jaw member 764a. The band electrode 766 is deployable to deliver energy. The band electrode 766 is configured to deliver energy, for example, to a tissue section in contact with the band electrode 766. FIG. 33 illustrates the band electrode 766 in a retracted position. In some embodiments, the band electrode 766 is configured to lay flush with the first jaw member 764a in a first, or retracted, position. The band electrode 766 is configured to flex outwardly from the first jaw member 764a in a second, or deployed, position, as illustrated in FIG. 32.


The first jaw member 764a comprises a first contact area 765a and the second jaw member 764b comprises a second contact area 765b. The first and second jaw members 764a, 764b are configured to grasp tissue therebetween. In some embodiments, the first contact area 765a and/or the second contact area 765b comprise energy delivery surfaces configured to deliver energy. The energy delivery surfaces 765a, 765b may deliver, for example, therapeutic RF energy, sub-therapeutic RF energy, ultrasonic energy, or any combination thereof. The first and second contact areas 765a, 765b may be configured to provide energy to a tissue section grasped between the first jaw member 764a and the second jaw member 764b. In some embodiments, the first contact area 765a and/or the second contact area 765b comprises a return electrode for energy delivered to a tissue section by the band electrode 766.


In some embodiments, a distal end of the band electrode 766 is fixedly connected to a distal end of the first jaw member 764a. The band electrode 766 is slideably moveable longitudinally relative to the fixed distal end. When the band electrode 766 is slideably moved in a distal direction, the fixed distal end of the band electrode 766 causes the band electrode 766 to flex away from the first jaw member 764a. When the band electrode is slideably moved in a proximal direction, the fixed distal end causes the band electrode 766 to lay flush with the first jaw member 764a.


In some embodiments, the first jaw member 764a comprises a band channel 768. The band electrode 766 is receivable within the band channel 768 in a retracted state. For example, if the band electrode 766 is moved in a proximal direction with respect to the fixed distal end, the band electrode 766 will lay flush against the first jaw member 764a. The band channel 768 receives the band electrode 766. When the band electrode 766 is in a retracted state, the band electrode 766 is flush with or below the outer surface of the first jaw member 764a. In various embodiments, the band channel 768 comprises a longitudinal channel defined by the outer surface of the first jaw member 764a.


It will be appreciated that the terms “proximal” and “distal” are used throughout the specification with reference to a clinician manipulating one end of an instrument used to treat a patient. The term “proximal” refers to the portion of the instrument closest to the clinician and the term “distal” refers to the portion located furthest from the clinician. It will further be appreciated that for conciseness and clarity, spatial terms such as “vertical,” “horizontal,” “up,” or “down” may be used herein with respect to the illustrated embodiments. However, surgical instruments may be used in many orientations and positions, and these terms are not intended to be limiting or absolute.


Various embodiments of surgical instruments and robotic surgical systems are described herein. It will be understood by those skilled in the art that the various embodiments described herein may be used with the described surgical instruments and robotic surgical systems. The descriptions are provided for example only, and those skilled in the art will understand that the disclosed embodiments are not limited to only the devices disclosed herein, but may be used with any compatible surgical instrument or robotic surgical system.


Reference throughout the specification to “various embodiments,” “some embodiments,” “one example embodiment,” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one example embodiment. Thus, appearances of the phrases “in various embodiments,” “in some embodiments,” “in one example embodiment,” or “in an embodiment” in places throughout the specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics illustrated or described in connection with one example embodiment may be combined, in whole or in part, with features, structures, or characteristics of one or more other embodiments without limitation.


While various embodiments herein have been illustrated by description of several embodiments and while the illustrative embodiments have been described in considerable detail, it is not the intention of the applicant to restrict or in any way limit the scope of the appended claims to such detail. Additional advantages and modifications may readily appear to those skilled in the art. For example, it is generally accepted that endoscopic procedures are more common than laparoscopic procedures. Accordingly, the present invention has been discussed in terms of endoscopic procedures and apparatus. However, use herein of terms such as “endoscopic”, should not be construed to limit the present invention to an instrument for use only in conjunction with an endoscopic tube (e.g., trocar). On the contrary, it is believed that the present invention may find use in any procedure where access is limited to a small incision, including but not limited to laparoscopic procedures, as well as open procedures.


It is to be understood that at least some of the figures and descriptions herein have been simplified to illustrate elements that are relevant for a clear understanding of the disclosure, while eliminating, for purposes of clarity, other elements. Those of ordinary skill in the art will recognize, however, that these and other elements may be desirable. However, because such elements are well known in the art, and because they do not facilitate a better understanding of the disclosure, a discussion of such elements is not provided herein.


While several embodiments have been described, it should be apparent, however, that various modifications, alterations and adaptations to those embodiments may occur to persons skilled in the art with the attainment of some or all of the advantages of the disclosure. For example, according to various embodiments, a single component may be replaced by multiple components, and multiple components may be replaced by a single component, to perform a given function or functions. This application is therefore intended to cover all such modifications, alterations and adaptations without departing from the scope and spirit of the disclosure as defined by the appended claims.


Any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated materials does not conflict with existing definitions, statements, or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.


Various aspects of the subject matter described herein are set out in the following numbered clauses:


1. An end effector comprising: a first jaw member defining a first aperture at a distal end, the first jaw member comprising a first electrode located proximally of the first aperture, wherein the first electrode comprises a positive temperature coefficient (PTC) material; and a second jaw member defining a second aperture at a distal end, the second jaw member comprising a second electrode located proximally of the second aperture, wherein the second jaw member is operatively coupled to the first jaw member, wherein the first and second apertures are configured to define a single aperture when the first and second jaw members are in a closed position, wherein the second electrode comprises a PTC material, and wherein the first and second electrodes are configured to deliver energy.


2. The end effector of clause 1, wherein the first and second jaw members define a longitudinal channel, the end effector comprising a cutting member slideably receivable within the longitudinal channel, wherein the cutting member is deployable along the longitudinal channel, and wherein the longitudinal channel is located proximally of the first and second apertures.


3. The end effector of clause 2, wherein the first electrode comprises a first PTC (positive temperature coefficient) electrode and a second a PTC electrode, wherein the first PTC electrode is located on a first side of the channel and the second PTC electrode is located on a second side of the channel, and wherein the first and second PTC electrodes define a treatment region.


4. The end effector of clause 2, wherein the cutting member comprises an I-beam.


5. The end effector of clause 1, wherein the energy delivered by the first electrode comprises at least one of monopolar electrosurgical energy, bipolar electrosurgical energy, ultrasonic energy, or any combination thereof.


6. An end effector comprising: a first jaw member comprising a first proximal contact surface and a first distal contact surface, wherein the first proximal contact surface and the first distal contact surface define a first opening therebetween; a second jaw member comprising a second proximal contact surface and a second distal contact surface, wherein the second jaw member is operatively coupled to the first jaw member, wherein the second proximal contact surface and the second distal contact surface define a second opening therebetween, and wherein when the first and second jaw members are in a closed position the first and second openings define an aperture; and a first proximal electrode coupled to the first proximal contact surface, wherein the first proximal electrode is configured to deliver energy.


7. The end effector of clause 6, wherein when the first and second jaw members are in a closed position, the proximal contact surfaces define a proximal grasping region and the distal contact surfaces define a distal grasping region.


8. The end effector of clause 6, wherein the energy delivered to the first end effector comprises at least one of monopolar electrosurgical energy, bipolar electrosurgical energy, ultrasonic energy, or any combination thereof.


9. The end effector of clause 8, comprising a second proximal electrode coupled to the second proximal contact surface, wherein the second proximal electrode is configured as a return electrode for electrosurgical energy delivered by the first proximal electrode.


10. The end effector of clause 8, comprising a first distal electrode coupled to the first distal contact surface, wherein the first distal electrode is configured to deliver energy, wherein the energy delivered to the first distal electrode comprises at least one of monopolar electrosurgical energy, bipolar electrosurgical energy, ultrasonic energy, or any combination thereof.


11. The end effector of clause 10, comprising a second distal electrode coupled to the second distal contact surface, wherein the second distal electrode is configured as a return electrode for electrosurgical signal delivered by the first distal electrode.


12. The end effector of clause 6, wherein the first and second jaw members define a longitudinal channel, the end effector comprising a cutting member slideably receivable within the longitudinal channel, wherein the cutting member is deployable along the longitudinal channel.


13. An end effector comprising: a first jaw member operatively coupled to a second jaw member, the first and second jaw members each comprising a proximal contact region defined by a first width and a distal contact region defined by a second width, wherein the first width is greater than the second width, and wherein the distal contact region comprises a hook shape; a first electrode coupled to the first jaw member, the first electrode configured to deliver energy; and a cutting member slideably receivable within a longitudinal channel defined by the first and second jaw members, wherein the cutting member is deployable along the longitudinal channel.


14. The end effector of clause 13, wherein the cutting member comprises an I-beam.


15. The end effector of clause 13, wherein the first electrode comprises a continuous electrode coupled to the proximal contact region and the distal contact region of the first jaw member.


16. The end effector of clause 15, wherein the energy delivered by the first electrode comprises one of monopolar electrosurgical energy, bipolar electrosurgical energy, ultrasonic energy, or any combination thereof.


17. The end effector of clause 16, wherein the second electrode comprises a continuous electrode coupled to the proximal contact region and the distal contact region of the second jaw member.


18. The end effector of clause 16, comprising a second electrode coupled to the second jaw member, wherein the first electrode comprises a source electrode configured to deliver bipolar electrosurgical energy, and wherein the second electrode comprises a return electrode.


19. The end effector of clause 11, wherein the first width is about three millimeters, and wherein the second width is about five millimeters.


20. An end effector comprising: a first jaw member comprising a band electrode coupled to an outer surface of the first jaw member, wherein the band electrode is configured to lay flush with the first jaw member in a first position, and wherein the band electrode is configured to flex outwardly from the first jaw member in a second position, and wherein the band electrode is configured to deliver energy; and a second jaw member operatively coupled to the first jaw member.


21. The end effector of clause 20, wherein the energy delivered by the band electrode comprises monopolar electrosurgical energy, bipolar electrosurgical energy, ultrasonic energy, or any combination thereof.


22. The end effector of clause 20, comprising: a first electrode disposed on an inner surface of the first jaw member; and a second electrode disposed on an inner surface of the second jaw member, wherein the first and second electrodes are configured to deliver energy.


23. The end effector of clause 20, wherein a distal end of the band electrode is fixedly connected to a distal end of the first jaw member, wherein the band electrode is slideably moveable longitudinally relative to the fixed distal end.


24. The end effector of clause 23, wherein the longitudinal movement of the band electrode relative to the fixed distal end causes the band electrode to flex outwardly from the first jaw member.


25. The end effector of clause 24, wherein the first jaw member defines a channel on the outer surface, and wherein the band electrode is positioned within the channel in the first position.

Claims
  • 1. An end effector comprising: a first jaw member comprising a first proximal contact surface and a first distal contact surface, wherein the first proximal contact surface and the first distal contact surface define a first opening therebetween;a second jaw member comprising a second proximal contact surface and a second distal contact surface, wherein the second jaw member is operatively coupled to the first jaw member, wherein the second proximal contact surface and the second distal contact surface define a second opening therebetween, andwherein when the first and second jaw members are in a closed position the first and second openings define an aperture, and the proximal contact surfaces define a proximal grasping region, andwherein the first and second jaw members define a longitudinal channel, and the longitudinal channel extends along the proximal grasping region and terminates in a closed end proximal to the aperture; anda first proximal electrode coupled to the first proximal contact surface, wherein the first proximal electrode is configured to deliver energy, and the energy delivered to the first proximal electrode comprises at least one of monopolar electrosurgical energy, ultrasonic energy, or combination thereof.
  • 2. The end effector of claim 1, wherein when the first and second jaw members are in a closed position, the proximal contact surfaces define a proximal grasping region and the distal contact surfaces define a distal grasping region.
  • 3. The end effector of claim 1, comprising a first distal electrode coupled to the first distal contact surface, wherein the first distal electrode is configured to deliver energy, wherein the energy delivered to the first distal electrode comprises at least one of monopolar electrosurgical energy, ultrasonic energy, or combination thereof.
  • 4. The end effector of claim 1, further comprising a cutting member slideably receivable within the longitudinal channel, wherein the cutting member is deployable along the longitudinal channel.
  • 5. The end effector of claim 1, wherein at least one of the first proximal contact surface or the second proximal contact surface comprises a PTC material.
  • 6. An end effector comprising: a first jaw member comprising a first proximal contact surface and a first distal contact surface, wherein the first proximal contact surface and the first distal contact surface define a first opening therebetween;a second jaw member comprising a second proximal contact surface and a second distal contact surface, wherein the second jaw member is operatively coupled to the first jaw member, wherein the second proximal contact surface and the second distal contact surface define a second opening therebetween,wherein when the first and second jaw members are in a closed position, the first and second openings define an aperture, the proximal contact surfaces define a proximal grasping region, and the distal contact surfaces define a distal grasping region, andwherein the first and second jaw members define a longitudinal channel, and the longitudinal channel extends along the proximal grasping region and terminates in a closed end proximal to the aperture; anda first proximal electrode coupled to the first proximal contact surface, wherein the first proximal electrode is configured to deliver energy.
  • 7. The end effector of claim 6, wherein the energy delivered to the first proximal electrode comprises at least one of monopolar electrosurgical energy, bipolar electrosurgical energy, ultrasonic energy, or any combination thereof.
  • 8. The end effector of claim 6, further comprising a second proximal electrode coupled to the second proximal contact surface, wherein the second proximal electrode is configured as a return electrode for electrosurgical energy delivered by the first proximal electrode.
  • 9. The end effector of claim 6, further comprising a first distal electrode coupled to the first distal contact surface, wherein the first distal electrode is configured to deliver energy, wherein the energy delivered to the first distal electrode comprises at least one of monopolar electrosurgical energy, bipolar electrosurgical energy, ultrasonic energy, or any combination thereof.
  • 10. The end effector of claim 9, further comprising a second distal electrode coupled to the second distal contact surface, wherein the second distal electrode is configured as a return electrode for electrosurgical signal delivered by the first distal electrode.
  • 11. The end effector of claim 6, further comprising a cutting member slideably receivable within the longitudinal channel, wherein the cutting member is deployable along the longitudinal channel.
  • 12. The end effector of claim 6, wherein at least one of the first proximal contact surface or the second proximal contact surface comprises a PTC material.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims benefit under 35 U.S.C. §119(e) to U.S. Provisional Patent Application 61/707,030, filed on Sep. 28, 2012, and entitled “MULTI-FUNCTION BI-POLAR FORCEPS,” which is hereby incorporated by reference in its entirety.

US Referenced Citations (554)
Number Name Date Kind
2366274 Luth et al. Jan 1945 A
2458152 Eakins Jan 1949 A
2510693 Green Jun 1950 A
3166971 Stoecker Jan 1965 A
3580841 Cadotte et al. May 1971 A
3703651 Blowers Nov 1972 A
3777760 Essner Dec 1973 A
4005714 Hiltebrandt Feb 1977 A
4034762 Cosens et al. Jul 1977 A
4058126 Leveen Nov 1977 A
4220154 Semm Sep 1980 A
4237441 van Konynenburg et al. Dec 1980 A
4281785 Brooks Aug 1981 A
4304987 van Konynenburg Dec 1981 A
4463759 Garito et al. Aug 1984 A
4492231 Auth Jan 1985 A
4535773 Yoon Aug 1985 A
4545926 Fouts, Jr. et al. Oct 1985 A
4550870 Krumme et al. Nov 1985 A
4582236 Hirose Apr 1986 A
4617927 Manes Oct 1986 A
4735603 Goodson et al. Apr 1988 A
4761871 O'Connor et al. Aug 1988 A
4830462 Karny et al. May 1989 A
4849133 Yoshida et al. Jul 1989 A
4860745 Farin et al. Aug 1989 A
4878493 Pasternak et al. Nov 1989 A
4910389 Sherman et al. Mar 1990 A
4920978 Colvin May 1990 A
5061269 Muller Oct 1991 A
5099840 Goble et al. Mar 1992 A
5104025 Main et al. Apr 1992 A
5106538 Barma et al. Apr 1992 A
5108383 White Apr 1992 A
5160334 Billings et al. Nov 1992 A
5190541 Abele et al. Mar 1993 A
5205459 Brinkerhoff et al. Apr 1993 A
5217460 Knoepfler Jun 1993 A
5234428 Kaufman Aug 1993 A
5258006 Rydell et al. Nov 1993 A
5285945 Brinkerhoff et al. Feb 1994 A
5290286 Parins Mar 1994 A
5309927 Welch May 1994 A
5318564 Eggers Jun 1994 A
5318589 Lichtman Jun 1994 A
5330471 Eggers Jul 1994 A
5339723 Huitema Aug 1994 A
5342359 Rydell Aug 1994 A
5361583 Huitema Nov 1994 A
5383874 Jackson et al. Jan 1995 A
5387207 Dyer et al. Feb 1995 A
5389098 Tsuruta et al. Feb 1995 A
5395312 Desai Mar 1995 A
5395364 Anderhub et al. Mar 1995 A
5396900 Slater et al. Mar 1995 A
5403312 Yates et al. Apr 1995 A
5417709 Slater May 1995 A
5428504 Bhatla Jun 1995 A
5429131 Scheinman et al. Jul 1995 A
5443463 Stern et al. Aug 1995 A
5445638 Rydell et al. Aug 1995 A
5451227 Michaelson Sep 1995 A
5458598 Feinberg et al. Oct 1995 A
5465895 Knodel et al. Nov 1995 A
5472443 Cordis et al. Dec 1995 A
5476479 Green et al. Dec 1995 A
5480409 Riza Jan 1996 A
5484436 Eggers et al. Jan 1996 A
5486189 Mudry et al. Jan 1996 A
5496317 Goble et al. Mar 1996 A
5504650 Katsui et al. Apr 1996 A
5509922 Aranyi et al. Apr 1996 A
5511556 DeSantis Apr 1996 A
5520704 Castro et al. May 1996 A
5522839 Pilling Jun 1996 A
5531744 Nardella et al. Jul 1996 A
5542916 Hirsch et al. Aug 1996 A
5558671 Yates Sep 1996 A
5563179 Stone et al. Oct 1996 A
5571121 Heifetz Nov 1996 A
5573534 Stone Nov 1996 A
5584830 Ladd et al. Dec 1996 A
5599350 Schulze et al. Feb 1997 A
5611813 Lichtman Mar 1997 A
5618307 Donlon et al. Apr 1997 A
5624452 Yates Apr 1997 A
5647871 Levine et al. Jul 1997 A
5658281 Heard Aug 1997 A
5662667 Knodel Sep 1997 A
5665085 Nardella Sep 1997 A
5665100 Yoon Sep 1997 A
5674219 Monson et al. Oct 1997 A
5674220 Fox et al. Oct 1997 A
5688270 Yates et al. Nov 1997 A
5693051 Schulze et al. Dec 1997 A
5709680 Yates et al. Jan 1998 A
5713896 Nardella Feb 1998 A
5716366 Yates Feb 1998 A
5735848 Yates et al. Apr 1998 A
5743906 Parins et al. Apr 1998 A
5752973 Kieturakis May 1998 A
5755717 Yates et al. May 1998 A
5762255 Chrisman et al. Jun 1998 A
5779701 McBrayer et al. Jul 1998 A
5782834 Lucey et al. Jul 1998 A
5792138 Shipp Aug 1998 A
5797941 Schulze et al. Aug 1998 A
5800432 Swanson Sep 1998 A
5800449 Wales Sep 1998 A
5807393 Williamson, IV et al. Sep 1998 A
5810811 Yates et al. Sep 1998 A
5817033 DeSantis et al. Oct 1998 A
5817093 Williamson, IV et al. Oct 1998 A
5836909 Cosmescu Nov 1998 A
5836943 Miller, III Nov 1998 A
5853412 Mayenberger Dec 1998 A
5876401 Schulze et al. Mar 1999 A
5880668 Hall Mar 1999 A
5891142 Eggers et al. Apr 1999 A
5906625 Bito et al. May 1999 A
5984938 Yoon Nov 1999 A
6003517 Sheffield et al. Dec 1999 A
6013052 Durman et al. Jan 2000 A
6024741 Williamson, IV et al. Feb 2000 A
6024744 Kese et al. Feb 2000 A
6033399 Gines Mar 2000 A
6039734 Goble Mar 2000 A
6050996 Schmaltz et al. Apr 2000 A
6063098 Houser et al. May 2000 A
6068629 Haissaguerre et al. May 2000 A
6074389 Levine et al. Jun 2000 A
6091995 Ingle et al. Jul 2000 A
6099483 Palmer et al. Aug 2000 A
6099550 Yoon Aug 2000 A
H1904 Yates et al. Oct 2000 H
6144402 Norsworthy et al. Nov 2000 A
6152923 Ryan Nov 2000 A
6174309 Wrublewski et al. Jan 2001 B1
6206876 Levine et al. Mar 2001 B1
6228080 Gines May 2001 B1
6259230 Chou Jul 2001 B1
6277117 Tetzlaff et al. Aug 2001 B1
6292700 Morrison et al. Sep 2001 B1
6325799 Goble Dec 2001 B1
6340878 Oglesbee Jan 2002 B1
6391026 Hung et al. May 2002 B1
6398779 Buysse et al. Jun 2002 B1
H2037 Yates et al. Jul 2002 H
6419675 Gallo, Sr. Jul 2002 B1
6430446 Knowlton Aug 2002 B1
6443968 Holthaus et al. Sep 2002 B1
6458128 Schulze Oct 2002 B1
6464702 Schulze et al. Oct 2002 B2
6500112 Khouri Dec 2002 B1
6500176 Truckai et al. Dec 2002 B1
6503248 Levine Jan 2003 B1
6511480 Tetzlaff et al. Jan 2003 B1
6514252 Nezhat et al. Feb 2003 B2
6517565 Whitman et al. Feb 2003 B1
6531846 Smith Mar 2003 B1
6533784 Truckai et al. Mar 2003 B2
6537272 Christopherson et al. Mar 2003 B2
6554829 Schulze et al. Apr 2003 B2
6558376 Bishop May 2003 B2
6572639 Ingle et al. Jun 2003 B1
6575969 Rittman, III et al. Jun 2003 B1
6584360 Francischelli et al. Jun 2003 B2
6585735 Lands et al. Jul 2003 B1
6589200 Schwemberger et al. Jul 2003 B1
6602252 Mollenauer Aug 2003 B2
6620161 Schulze et al. Sep 2003 B2
6622731 Daniel et al. Sep 2003 B2
6623482 Pendekanti et al. Sep 2003 B2
6635057 Harano et al. Oct 2003 B2
6651669 Burnside Nov 2003 B1
6656177 Truckai et al. Dec 2003 B2
6656198 Tsonton et al. Dec 2003 B2
6673248 Chowdhury Jan 2004 B2
6679882 Kornerup Jan 2004 B1
6695840 Schulze Feb 2004 B2
6722552 Fenton, Jr. Apr 2004 B2
6770072 Truckai et al. Aug 2004 B1
6773409 Truckai et al. Aug 2004 B2
6773435 Schulze et al. Aug 2004 B2
6789939 Schrödinger et al. Sep 2004 B2
6796981 Wham et al. Sep 2004 B2
6800085 Selmon et al. Oct 2004 B2
6802843 Truckai et al. Oct 2004 B2
6811842 Ehrnsperger et al. Nov 2004 B1
6821273 Mollenauer Nov 2004 B2
6835199 McGuckin, Jr. et al. Dec 2004 B2
6840938 Morley et al. Jan 2005 B1
6860880 Treat et al. Mar 2005 B2
6905497 Truckai et al. Jun 2005 B2
6908463 Treat et al. Jun 2005 B2
6913579 Truckai et al. Jul 2005 B2
6926716 Baker et al. Aug 2005 B2
6929622 Chian Aug 2005 B2
6929644 Truckai et al. Aug 2005 B2
6953461 McClurken et al. Oct 2005 B2
7000818 Shelton, IV et al. Feb 2006 B2
7011657 Truckai et al. Mar 2006 B2
7041102 Truckai et al. May 2006 B2
7052496 Yamauchi May 2006 B2
7055731 Shelton, IV et al. Jun 2006 B2
7063699 Hess et al. Jun 2006 B2
7066936 Ryan Jun 2006 B2
7070597 Truckai et al. Jul 2006 B2
7083618 Couture et al. Aug 2006 B2
7083619 Truckai et al. Aug 2006 B2
7087054 Truckai et al. Aug 2006 B2
7094235 Francischelli et al. Aug 2006 B2
7101371 Dycus et al. Sep 2006 B2
7101372 Dycus et al. Sep 2006 B2
7101373 Dycus et al. Sep 2006 B2
7112201 Truckai et al. Sep 2006 B2
7118570 Tetzlaff et al. Oct 2006 B2
7125409 Truckai et al. Oct 2006 B2
7131970 Moses et al. Nov 2006 B2
7137980 Buysse et al. Nov 2006 B2
7143925 Shelton, IV et al. Dec 2006 B2
7147138 Shelton, IV Dec 2006 B2
7156846 Dycus et al. Jan 2007 B2
7160296 Pearson et al. Jan 2007 B2
7169146 Truckai et al. Jan 2007 B2
7169156 Hart Jan 2007 B2
7186253 Truckai et al. Mar 2007 B2
7189233 Truckai et al. Mar 2007 B2
7195631 Dumbauld Mar 2007 B2
7207471 Heinrich et al. Apr 2007 B2
7220951 Truckai et al. May 2007 B2
7225964 Mastri et al. Jun 2007 B2
7226448 Bertolero et al. Jun 2007 B2
7232440 Dumbauld et al. Jun 2007 B2
7235073 Levine et al. Jun 2007 B2
7241294 Reschke Jul 2007 B2
7251531 Mosher et al. Jul 2007 B2
7252667 Moses et al. Aug 2007 B2
7267677 Johnson et al. Sep 2007 B2
7267685 Butaric et al. Sep 2007 B2
7287682 Ezzat et al. Oct 2007 B1
7300450 Vleugels et al. Nov 2007 B2
7303557 Wham et al. Dec 2007 B2
7307313 Ohyanagi et al. Dec 2007 B2
7309849 Truckai et al. Dec 2007 B2
7311709 Truckai et al. Dec 2007 B2
7329257 Kanehira et al. Feb 2008 B2
7354440 Truckal et al. Apr 2008 B2
7357287 Shelton, IV et al. Apr 2008 B2
7364577 Wham et al. Apr 2008 B2
7367976 Lawes et al. May 2008 B2
7371227 Zeiner May 2008 B2
RE40388 Gines Jun 2008 E
7381209 Truckai et al. Jun 2008 B2
7396356 Mollenauer Jul 2008 B2
7403224 Fuller et al. Jul 2008 B2
7404508 Smith et al. Jul 2008 B2
7407077 Ortiz et al. Aug 2008 B2
7422139 Shelton, IV et al. Sep 2008 B2
7435582 Zimmermann et al. Oct 2008 B2
7442193 Shields et al. Oct 2008 B2
7445621 Dumbauld et al. Nov 2008 B2
7464846 Shelton, IV et al. Dec 2008 B2
7473253 Dycus et al. Jan 2009 B2
7488319 Yates Feb 2009 B2
7491201 Shields et al. Feb 2009 B2
7494501 Ahlberg et al. Feb 2009 B2
7498080 Tung et al. Mar 2009 B2
7510107 Timm et al. Mar 2009 B2
7513025 Fischer Apr 2009 B2
7517349 Truckai et al. Apr 2009 B2
7540872 Schechter et al. Jun 2009 B2
7550216 Ofer et al. Jun 2009 B2
7559452 Wales et al. Jul 2009 B2
7582086 Privitera et al. Sep 2009 B2
7586289 Andruk et al. Sep 2009 B2
7588176 Timm et al. Sep 2009 B2
7594925 Danek et al. Sep 2009 B2
7597693 Garrison Oct 2009 B2
7604150 Boudreaux Oct 2009 B2
7628791 Garrison et al. Dec 2009 B2
7628792 Guerra Dec 2009 B2
7632267 Dahla Dec 2009 B2
7632269 Truckai et al. Dec 2009 B2
7641653 Dalla Betta et al. Jan 2010 B2
7641671 Crainich Jan 2010 B2
7644848 Swayze et al. Jan 2010 B2
7645277 McClurken et al. Jan 2010 B2
7648499 Orszulak et al. Jan 2010 B2
7658311 Boudreaux Feb 2010 B2
7665647 Shelton, IV et al. Feb 2010 B2
7666206 Taniguchi et al. Feb 2010 B2
7703459 Saadat et al. Apr 2010 B2
7708751 Hughes et al. May 2010 B2
7722607 Dumbauld et al. May 2010 B2
7753904 Shelton, IV et al. Jul 2010 B2
7753908 Swanson Jul 2010 B2
7762445 Heinrich et al. Jul 2010 B2
7766910 Hixson et al. Aug 2010 B2
7776037 Odom Aug 2010 B2
7780663 Yates et al. Aug 2010 B2
7784663 Shelton, IV Aug 2010 B2
7803156 Eder et al. Sep 2010 B2
7815641 Dodde et al. Oct 2010 B2
7819298 Hall et al. Oct 2010 B2
7819299 Sheltoin, IV et al. Oct 2010 B2
7832408 Shelton, IV et al. Nov 2010 B2
7832612 Baxter, III et al. Nov 2010 B2
7846159 Morrison et al. Dec 2010 B2
7846160 Payne et al. Dec 2010 B2
7879035 Garrison et al. Feb 2011 B2
7879070 Ortiz et al. Feb 2011 B2
7901400 Wham et al. Mar 2011 B2
7931649 Couture et al. Apr 2011 B2
7935114 Takashino et al. May 2011 B2
7955331 Truckai et al. Jun 2011 B2
7963963 Francischelli et al. Jun 2011 B2
7967602 Lindquist Jun 2011 B2
7981113 Truckai et al. Jul 2011 B2
7997278 Utley et al. Aug 2011 B2
8020743 Shelton, IV Sep 2011 B2
8058771 Giordano et al. Nov 2011 B2
8070036 Knodel et al. Dec 2011 B1
8105323 Buysse et al. Jan 2012 B2
8128624 Couture et al. Mar 2012 B2
8136712 Zingman Mar 2012 B2
8141762 Bedi et al. Mar 2012 B2
8157145 Shelton, IV et al. Apr 2012 B2
8197472 Lau et al. Jun 2012 B2
8197479 Olson et al. Jun 2012 B2
8221415 Francischelli Jul 2012 B2
8246615 Behnke Aug 2012 B2
8246618 Bucciaglia et al. Aug 2012 B2
8251994 McKenna et al. Aug 2012 B2
8262563 Bakos et al. Sep 2012 B2
8277446 Heard Oct 2012 B2
8277447 Garrison et al. Oct 2012 B2
8282669 Gerber et al. Oct 2012 B2
8287528 Wham et al. Oct 2012 B2
8292886 Kerr et al. Oct 2012 B2
8298232 Unger Oct 2012 B2
8303583 Hosier et al. Nov 2012 B2
8323310 Kingsley Dec 2012 B2
8377059 Deville et al. Feb 2013 B2
8397971 Yates et al. Mar 2013 B2
8414577 Boudreaux et al. Apr 2013 B2
8430876 Kappus et al. Apr 2013 B2
8453906 Huang et al. Jun 2013 B2
8460288 Tamai et al. Jun 2013 B2
8460292 Truckai et al. Jun 2013 B2
8486057 Behnke, II Jul 2013 B2
8496682 Guerra et al. Jul 2013 B2
8535311 Schall Sep 2013 B2
8562598 Falkenstein et al. Oct 2013 B2
8562604 Nishimura Oct 2013 B2
8568412 Brandt et al. Oct 2013 B2
8569997 Lee Oct 2013 B2
8574231 Boudreaux et al. Nov 2013 B2
8591506 Wham et al. Nov 2013 B2
8613383 Beckman et al. Dec 2013 B2
8623044 Timm et al. Jan 2014 B2
8628529 Aldridge et al. Jan 2014 B2
8632461 Glossop Jan 2014 B2
8647350 Mohan et al. Feb 2014 B2
8663222 Anderson et al. Mar 2014 B2
8685020 Weizman et al. Apr 2014 B2
8696665 Hunt et al. Apr 2014 B2
8702609 Hadjicostis Apr 2014 B2
8702704 Shelton, IV et al. Apr 2014 B2
8709035 Johnson et al. Apr 2014 B2
8715270 Weitzner et al. May 2014 B2
8715277 Weizman May 2014 B2
8734443 Hixson et al. May 2014 B2
8747404 Boudreaux et al. Jun 2014 B2
8753338 Widenhouse et al. Jun 2014 B2
8764747 Cummings et al. Jul 2014 B2
8790342 Stulen et al. Jul 2014 B2
8795276 Dietz et al. Aug 2014 B2
8795327 Dietz et al. Aug 2014 B2
8834466 Cummings et al. Sep 2014 B2
8834518 Faller et al. Sep 2014 B2
8888776 Dietz et al. Nov 2014 B2
8906016 Boudreaux et al. Dec 2014 B2
8926608 Bacher et al. Jan 2015 B2
8939974 Boudreaux et al. Jan 2015 B2
8951248 Messerly et al. Feb 2015 B2
8956349 Aldridge et al. Feb 2015 B2
8979843 Timm et al. Mar 2015 B2
8979844 White et al. Mar 2015 B2
8986302 Aldridge et al. Mar 2015 B2
9005199 Beckman et al. Apr 2015 B2
9011437 Woodruff et al. Apr 2015 B2
9044243 Johnson et al. Jun 2015 B2
20020022836 Goble et al. Feb 2002 A1
20020165541 Whitman Nov 2002 A1
20020183734 Bommannan et al. Dec 2002 A1
20030014053 Nguyen et al. Jan 2003 A1
20030105474 Bonutti Jun 2003 A1
20030114851 Truckai et al. Jun 2003 A1
20030130693 Levin et al. Jul 2003 A1
20030139741 Goble Jul 2003 A1
20030158548 Phan et al. Aug 2003 A1
20030216722 Swanson Nov 2003 A1
20030229344 Dycus et al. Dec 2003 A1
20040019350 O'Brien et al. Jan 2004 A1
20040092992 Adams et al. May 2004 A1
20040138621 Jahns et al. Jul 2004 A1
20040167508 Wham et al. Aug 2004 A1
20040193150 Sharkey et al. Sep 2004 A1
20040232196 Shelton, IV et al. Nov 2004 A1
20040249374 Tetzlaff et al. Dec 2004 A1
20040260273 Wan Dec 2004 A1
20050015125 Mioduski et al. Jan 2005 A1
20050033278 McClurken et al. Feb 2005 A1
20050085809 Mucko et al. Apr 2005 A1
20050090817 Phan Apr 2005 A1
20050131390 Heinrich Jun 2005 A1
20050165429 Douglas et al. Jul 2005 A1
20050171522 Christopherson Aug 2005 A1
20050203507 Truckai et al. Sep 2005 A1
20050261581 Hughes et al. Nov 2005 A1
20050267464 Truckai et al. Dec 2005 A1
20060052778 Chapman et al. Mar 2006 A1
20060064086 Odom Mar 2006 A1
20060069388 Truckai et al. Mar 2006 A1
20060159731 Shoshan Jul 2006 A1
20060270916 Skwarek et al. Nov 2006 A1
20060293656 Shadduck et al. Dec 2006 A1
20070027469 Smith et al. Feb 2007 A1
20070073185 Nakao Mar 2007 A1
20070073341 Smith et al. Mar 2007 A1
20070106158 Madan et al. May 2007 A1
20070146113 Truckai et al. Jun 2007 A1
20070173803 Wham et al. Jul 2007 A1
20070173813 Odom Jul 2007 A1
20070185474 Nahen Aug 2007 A1
20070191713 Eichmann et al. Aug 2007 A1
20070191830 Cromton, Jr. et al. Aug 2007 A1
20070203483 Kim et al. Aug 2007 A1
20070208312 Norton et al. Sep 2007 A1
20070232920 Kowalski et al. Oct 2007 A1
20070232926 Stulen et al. Oct 2007 A1
20070232927 Madan et al. Oct 2007 A1
20070232928 Wiener et al. Oct 2007 A1
20070236213 Paden et al. Oct 2007 A1
20070239025 Wiener et al. Oct 2007 A1
20070260242 Dycus et al. Nov 2007 A1
20070265613 Edelstein et al. Nov 2007 A1
20080015575 Odom et al. Jan 2008 A1
20080071269 Hilario et al. Mar 2008 A1
20080114355 Whayne et al. May 2008 A1
20080147058 Horrell et al. Jun 2008 A1
20080147062 Truckai et al. Jun 2008 A1
20080167522 Giordano et al. Jul 2008 A1
20080188755 Hart Aug 2008 A1
20080188851 Truckai et al. Aug 2008 A1
20080188912 Stone et al. Aug 2008 A1
20080221565 Eder et al. Sep 2008 A1
20080262491 Swoyer et al. Oct 2008 A1
20080269862 Elmouelhi et al. Oct 2008 A1
20080281315 Gines Nov 2008 A1
20080294158 Pappone et al. Nov 2008 A1
20090012516 Curtis et al. Jan 2009 A1
20090048589 Takashino et al. Feb 2009 A1
20090076506 Baker Mar 2009 A1
20090076534 Shelton, IV et al. Mar 2009 A1
20090099582 Isaacs et al. Apr 2009 A1
20090125026 Rioux et al. May 2009 A1
20090125027 Fischer May 2009 A1
20090138003 Deville et al. May 2009 A1
20090138006 Bales et al. May 2009 A1
20090182332 Long et al. Jul 2009 A1
20090206140 Scheib et al. Aug 2009 A1
20090209979 Yates et al. Aug 2009 A1
20090248002 Takashino et al. Oct 2009 A1
20090248021 McKenna Oct 2009 A1
20090320268 Cunningham et al. Dec 2009 A1
20090326530 Orban, III et al. Dec 2009 A1
20100032470 Hess et al. Feb 2010 A1
20100036370 Mirel et al. Feb 2010 A1
20100036380 Taylor et al. Feb 2010 A1
20100076433 Taylor et al. Mar 2010 A1
20100081863 Hess et al. Apr 2010 A1
20100081864 Hess et al. Apr 2010 A1
20100081880 Widenhouse et al. Apr 2010 A1
20100081881 Murray et al. Apr 2010 A1
20100081882 Hess et al. Apr 2010 A1
20100081883 Murray et al. Apr 2010 A1
20100081995 Widenhouse et al. Apr 2010 A1
20100094323 Isaacs et al. Apr 2010 A1
20100168620 Klimovitch et al. Jul 2010 A1
20100222752 Collins, Jr. et al. Sep 2010 A1
20100237132 Measamer et al. Sep 2010 A1
20100264194 Huang et al. Oct 2010 A1
20100274278 Fleenor et al. Oct 2010 A1
20110015627 DiNardo et al. Jan 2011 A1
20110082486 Messerly et al. Apr 2011 A1
20110087214 Giordano et al. Apr 2011 A1
20110087215 Aldridge et al. Apr 2011 A1
20110087216 Aldridge et al. Apr 2011 A1
20110087217 Yates et al. Apr 2011 A1
20110087220 Felder et al. Apr 2011 A1
20110155781 Swensgard et al. Jun 2011 A1
20110224668 Johnson et al. Sep 2011 A1
20110276049 Gerhardt Nov 2011 A1
20110276057 Conlon et al. Nov 2011 A1
20110301605 Horner Dec 2011 A1
20110306965 Norvell et al. Dec 2011 A1
20110306967 Payne et al. Dec 2011 A1
20120010616 Huang et al. Jan 2012 A1
20120016413 Timm et al. Jan 2012 A1
20120022519 Huang et al. Jan 2012 A1
20120022526 Aldridge et al. Jan 2012 A1
20120022527 Woodruff et al. Jan 2012 A1
20120078248 Worrell et al. Mar 2012 A1
20120083783 Davison et al. Apr 2012 A1
20120109186 Parrott et al. May 2012 A1
20120116379 Yates et al. May 2012 A1
20120116391 Houser et al. May 2012 A1
20120130256 Buysse et al. May 2012 A1
20120136353 Romero May 2012 A1
20120150170 Buysse et al. Jun 2012 A1
20120172859 Condie et al. Jul 2012 A1
20120265196 Turner et al. Oct 2012 A1
20130023875 Harris et al. Jan 2013 A1
20130030433 Heard Jan 2013 A1
20130079762 Twomey et al. Mar 2013 A1
20130085496 Unger et al. Apr 2013 A1
20130103023 Monson et al. Apr 2013 A1
20130103024 Monson et al. Apr 2013 A1
20130123776 Monson et al. May 2013 A1
20130123777 Monson et al. May 2013 A1
20130123782 Trees et al. May 2013 A1
20130131660 Monson et al. May 2013 A1
20130253502 Aronow et al. Sep 2013 A1
20130338661 Behnke, II Dec 2013 A1
20140005680 Shelton, IV et al. Jan 2014 A1
20140148806 Witt et al. May 2014 A1
20140194914 Hunt et al. Jul 2014 A1
20140194915 Johnson et al. Jul 2014 A1
20140257284 Artale Sep 2014 A1
20140330271 Dietz et al. Nov 2014 A1
20140343550 Faller et al. Nov 2014 A1
20150018826 Boudreaux Jan 2015 A1
20150066022 Shelton, IV et al. Mar 2015 A1
20150080876 Worrell et al. Mar 2015 A1
20150080879 Trees et al. Mar 2015 A1
20150080891 Shelton, IV et al. Mar 2015 A1
20150133915 Strobl et al. May 2015 A1
20150133921 Strobl et al. May 2015 A1
20150190189 Yates et al. Jul 2015 A1
20150196352 Beckman et al. Jul 2015 A1
20150201953 Strobl et al. Jul 2015 A1
20150230853 Johnson et al. Aug 2015 A1
Foreign Referenced Citations (80)
Number Date Country
29623113 Oct 1997 DE
20004812 Sep 2000 DE
10201569 Jul 2003 DE
0340803 Aug 1993 EP
0630612 Dec 1994 EP
0705571 Apr 1996 EP
0640317 Sep 1999 EP
0722696 Dec 2002 EP
1293172 Apr 2006 EP
1749479 Feb 2007 EP
1767157 Mar 2007 EP
1878399 Jan 2008 EP
1915953 Apr 2008 EP
1532933 May 2008 EP
1707143 Jun 2008 EP
1943957 Jul 2008 EP
1849424 Apr 2009 EP
2042117 Apr 2009 EP
2060238 May 2009 EP
1810625 Aug 2009 EP
2090238 Aug 2009 EP
2090256 Aug 2009 EP
2092905 Aug 2009 EP
2105104 Sep 2009 EP
1747761 Oct 2009 EP
1769766 Feb 2010 EP
2151204 Feb 2010 EP
2153791 Feb 2010 EP
2243439 Oct 2010 EP
1728475 Aug 2011 EP
2353518 Aug 2011 EP
2508143 Feb 2014 EP
2472216 Feb 2011 GB
H 08-229050 Sep 1996 JP
2008-018226 Jan 2008 JP
WO 8103272 Nov 1981 WO
WO 9307817 Apr 1993 WO
WO 9322973 Nov 1993 WO
WO 9510978 Apr 1995 WO
WO 9635382 Nov 1996 WO
WO 9710764 Mar 1997 WO
WO 9800069 Jan 1998 WO
WO 9840020 Sep 1998 WO
WO 9857588 Dec 1998 WO
WO 9923960 May 1999 WO
WO 9940861 Aug 1999 WO
WO 0024330 May 2000 WO
WO 0024331 May 2000 WO
WO 0025691 May 2000 WO
WO 0128444 Apr 2001 WO
WO 02080797 Oct 2002 WO
WO 03001986 Jan 2003 WO
WO 03013374 Feb 2003 WO
WO 03020339 Mar 2003 WO
WO 03028541 Apr 2003 WO
WO 03030708 Apr 2003 WO
WO 03068046 Aug 2003 WO
WO 2004011037 Feb 2004 WO
WO 2004078051 Sep 2004 WO
WO 2005052959 Jun 2005 WO
WO 2006021269 Mar 2006 WO
WO 2006036706 Apr 2006 WO
WO 2006055166 May 2006 WO
WO 2008020964 Feb 2008 WO
WO 2008045348 Apr 2008 WO
WO 2008099529 Aug 2008 WO
WO 2008101356 Aug 2008 WO
WO 2009022614 Feb 2009 WO
WO 2009036818 Mar 2009 WO
WO 2009039179 Mar 2009 WO
WO 2009059741 May 2009 WO
WO 2009082477 Jul 2009 WO
WO 2009149234 Dec 2009 WO
WO 2010017266 Feb 2010 WO
WO 2010104755 Sep 2010 WO
WO 2011084768 Jul 2011 WO
WO 2011089717 Jul 2011 WO
WO 2011144911 Nov 2011 WO
WO 2013034629 Mar 2013 WO
WO 2013062978 May 2013 WO
Non-Patent Literature Citations (35)
Entry
International Search Report for PCT/US2013/060838, Mar. 19, 2014 (6 pages).
Arnoczky et al., “Thermal Modification of Conective Tissues: Basic Science Considerations and Clinical Implications,” J. Am Acad Orthop Surg, vol. 8, No. 5, pp. 305-313 (Sep./Oct. 2000).
Chen et al., “Heat-Induced Changes in the Mechanics of a Collagenous Tissue: Isothermal Free Shrinkage,” Transactions of the ASME, vol. 119, pp. 372-378 (Nov. 1997).
Chen et al., “Heat-Induced Changes in the Mechanics of a Collagenous Tissue: Isothermal, Isotonic Shrinkage,” Transactions of the ASME, vol. 120, pp. 382-388 (Jun. 1998).
Chen et al., “Heat-induced changes in the mechanics of a collagenous tissue: pseudoelastic behavior at 37° C,” Journal of Biomechanics, 31, pp. 211-216 (1998).
Chen et al., “Phenomenological Evolution Equations for Heat-Induced Shrinkage of a Collagenous Tissue,” IEEE Transactions on Biomedical Engineering, vol. 45, No. 10, pp. 1234-1240 (Oct. 1998).
Covidien Brochure, [Value Analysis Brief], LigaSure Advance™ Pistol Grip, dated Rev. Apr. 2010 (7 pages).
Covidien Brochure, LigaSure Atlas™ Hand Switching Instruments, dated Dec. 2008 (2 pages).
Covidien Brochure, LigaSure Impact™ Instrument LF4318, dated Feb. 2013 (3 pages).
Covidien Brochure, The LigaSure Precise™ Instrument, dated Mar. 2011 (2 pages).
Covidien Brochure, The LigaSure™ 5 mm Blunt Tip Sealer/Divider Family, dated Apr. 2013 (2 pages).
Douglas, S.C. “Introduction to Adaptive Filter”. Digital Signal Processing Handbook. Ed. Vijay K. Madisetti and Douglas B. Williams. Boca Raton: CRC Press LLC, 1999.
Erbe Electrosurgery VIO® 200 S, (2012), p. 7, 12 pages, accessed Mar. 31, 2014 at http://www.erbe-med.com/erbe/media/Marketingmaterialien/85140-170—ERBE—EN—VIO—200—S D027541.
Gibson, “Magnetic Refrigerator Successfully Tested,” U.S. Department of Energy Research News, accessed online on Aug. 6, 2010 at http://www.eurekalert.org/features/doe/2001-11/dl-mrs062802.php (Nov. 1, 2001).
Glaser and Subak-Sharpe, Integrated Circuit Engineering, Addison-Wesley Publishing, Reading, MA (1979).
Harris et al., “Altered Mechanical Behavior of Epicardium Due to Isothermal Heating Under Biaxial Isotonic Loads,” Journal of Biomechanical Engineering, vol. 125, pp. 381-388 (Jun. 2003).
Harris et al., “Kinetics of Thermal Damage to a Collagenous Membrane Under Biaxial Isotonic Loading,” IEEE Transactions on Biomedical Engineering, vol. 51, No. 2, pp. 371-379 (Feb. 2004).
Hayashi et al., “The Effect of Thermal Heating on the Length and Histologic Properties of the Glenohumeral Joint Capsule,” American Journal of Sports Medicine, vol. 25, Issue 1, 11 pages (Jan. 1997), URL: http://www.mdconsult.com/das/article/body/156183648-2/jorg=journal&source=MI&sp=1 . . . , accessed Aug. 25, 2009.
Henriques. F.C., “Studies in thermal injury V. The predictability and the significance of thermally induced rate processes leading to irreversible epidermal injury.” Archives of Pathology, 434, pp. 489-502 (1947).
Hörmann et al., “Reversible and irreversible denaturation of collagen fibers.” Biochemistry, 10, pp. 932-937 (1971).
Humphrey, J.D., “Continuum Thermomechanics and the Clinical Treatment of Disease and Injury,” Appl. Mech. Rev., vol. 56, No. 2 pp. 231-260 (Mar. 2003).
Jang, J. et al. “Neuro-fuzzy and Soft Computing.” Prentice Hall, 1997, pp. 13-89, 199-293, 335-393,453-496, 535-549.
Kurt Gieck & Reiner Gieck, Engineering Formulas § Z.7 (7th ed. 1997).
Lee et al., “A multi-sample denaturation temperature tester for collagenous biomaterials,” Med. Eng. Phy., vol. 17, No. 2, pp. 115-121 (Mar. 1995).
Moran et al., “Thermally Induced Shrinkage of Joint Capsule,” Clinical Orthopaedics and Related Research, No. 281, pp. 248-255 (Dec. 2000).
National Semiconductors Temperature Sensor Handbook—http://www.national.com/appinfo/tempsensors/files/temphb.pdf; accessed online: Apr. 1, 2011.
Sullivan, “Cost-Constrained Selection of Strand Diameter and Number in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 16, No. 2, Mar. 2001, pp. 281-288.
Sullivan, “Optimal Choice for Number of Strands in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 14, No. 2, Mar. 1999, pp. 283-291.
Wall et al., “Thermal modification of collagen,” J Shoulder Elbow Surg, No. 8, pp. 339-344 (Jul./Aug. 1999).
Weir, C.E., “Rate of shrinkage of tendon collagen—heat, entropy and free energy of activation of the shrinkage of untreated tendon. Effect of acid salt, pickle, and tannage on the activation of tendon collagen.” Journal of the American Leather Chemists Association, 44, pp. 108-140 (1949).
Wells et al., “Altered Mechanical Behavior of Epicardium Under Isothermal Biaxial Loading,” Transactions of the ASME, Journal of Biomedical Engineering, vol. 126, pp. 492-497 (Aug. 2004).
Wright, et al., “Time-Temperature Equivalence of Heat-Induced Changes in Cells and Proteins,” Feb. 1998. ASME Journal of Biomechanical Engineering, vol. 120, pp. 22-26.
U.S. Appl. No. 14/218,558, filed Mar. 18, 2014.
U.S. Appl. No. 14/227,699, filed Mar. 27, 2014.
U.S. Appl. No. 14/227,708, filed Mar. 27, 2014.
Related Publications (1)
Number Date Country
20140094801 A1 Apr 2014 US
Provisional Applications (1)
Number Date Country
61707030 Sep 2012 US